Background
==========

Description of the problem or issue
-----------------------------------

Randomised trials are the gold standard for evaluating the effectiveness and efficacy of interventions. Non-response or loss to follow-up within study groups in randomised trials can compromise study findings by reducing the power of a study to detect a true difference between the control and the intervention group. Differential loss to follow-up may lead to bias through exaggerated effects in favour of one of the groups. This can affect the generalisability and internal validity of the trial and the results (Fewtrell [@b121]; Schulz [@b154]).

Missing data from loss to follow-up can be dealt with statistically by various methods including, for example, imputing values based on valid assumptions about the missing data to give a conservative estimate of the treatment effect. However, the risk of bias still remains when trials do not collect adequate data to give accurate estimates (Hollis [@b130]). Schulz and colleagues suggested that less than 5% loss to follow-up may lead to minimum bias, while 20% loss to follow-up can threaten trial validity, although the pattern of loss to follow-up by treatment may also be an important factor (Schulz [@b154]). Loss to follow-up from randomised trials can sometimes go unreported and using different, but plausible, assumptions about outcomes for participants lost to follow-up can change the results of randomised trials.

A number of trials have retrospectively examined the predictors of loss to follow-up in different disease areas (Arnow [@b105]; Snow [@b157]; Villarruel [@b166]). In a trial for the treatment of chronic major depression, Arnow examined the predictors of time to, and reason for, dropout of participants (Arnow [@b105]). Ethnic minorities and participants with comorbid anxiety were more likely to drop out. In a randomised trial of a human immunodeficiency virus (HIV) prevention intervention for Latino youths, English speakers were more likely to attend follow-up (Villarruel [@b166]). Snow examined the predictors of clinic attendance and dropout at the 11-year follow-up of the Lung Health study (Snow [@b157]). Age, gender, number of cigarettes smoked per day, marital status and whether participant\'s children smoked were predictors of clinic attendance. These analyses showed that attendance for follow-up can be trial and disease specific. An awareness of these factors can help trialists decide which strategies to adopt to improve retention in their randomised trial.

Description of the methods being investigated
---------------------------------------------

Strategies to improve trial retention include those designed to generate maximum data return or compliance to follow-up procedures. These can include frequency and timing of follow-up visits (follow-up shortly after randomisation versus long-term follow-up), nature of the outcome to be measured (survey based self reported outcomes versus morbidity or mortality reporting), target of the intervention (participants versus providers versus trial sites), and type of intervention (incentives versus communication strategies versus participant case management).

How these methods might work
----------------------------

These retention strategies are designed to motivate participants (Leathem [@b136]), or the trial site to continue participating in a trial once they have been recruited and randomised. Some strategies are designed to encourage participants to identify with the trial and to promote a sense of value and belonging, for example, using trial identity cards. Other strategies are designed to keep participants engaged in the trial, for example, by sending participant newsletters. To encourage a proactive approach to trial retention, strategies can be designed to target participants directly through letters, emails, telephone calls or to target them via the clinicians involved in participant follow-up, for example, through regular communication with trial sites. Strategies have been specifically developed to promote retention in areas of research where it is particularly challenging, such as mental health (Furimsky [@b124]; Loue [@b140]), weight loss ( Couper [@b14]; Goldberg [@b126]), rare diseases (McKinstry [@b142]), substance abuse (El [@b120]), research involving minority ethnic groups (Eakin [@b116]; Loftin [@b139]; Villacorta [@b165]), and vulnerable groups such as older people (Burns [@b109]) or people with HIV (Anastasi [@b104]).

Why it is important to do this review
-------------------------------------

As drop-out or incomplete data causes problems in the conduct, analysis and interpretation of randomised trials, it is important to identify retention strategies that minimise this loss as far as possible.

Davis and colleagues conducted a review of community-based trials published from 1990 to 1999 and described retention strategies and retention outcomes for this area (Davis [@b112]). Robinson and colleagues conducted a systematic review of strategies for retaining study participants (Robinson [@b152]). While both reviews identified studies providing data on retention rates from primary studies and strategies used to promote retention, these were not evaluated quantitatively in either review.

A systematic review of strategies to retain participants in population-based cohort studies found that providing incentives was consistently associated with retention in these studies and that response generally increased with increasing incentive value (Booker [@b107]). Reminder letters, repeat questionnaires and reminder calls also increased response rates. Furthermore, the Edwards et al. Cochrane methodology review on methods to increase response rates to postal and electronic questionnaires found that including monetary incentives, keeping the questionnaire short and contacting people before sending the questionnaire were ways to increase response rates (Edwards [@b118]). That review was not restricted to research exclusively within randomised trials and covered both healthcare and non-healthcare settings and it is difficult to know which of these strategies would be applicable to randomised trials in health care. Reasons for drop-out in cohort studies and surveys may differ from those in randomised trials. For example, in trials, participants may be randomised to a study group that is not their preferred choice and factors around randomisation and the type of intervention mean that strategies increasing retention in cohort studies and surveys cannot necessarily be extrapolated to randomised trials.

The challenges of boosting recruitment to randomised trials is often described alongside retention in the literature. Some similar strategies may be used in an attempt to both increase recruitment and improve retention, such as giving incentives together with extra information. Rendell et al. assessed the evidence for the effect of disincentives and incentives on the extent to which clinicians invite eligible people to participate in randomised trials of healthcare interventions (Rendell [@b150]). No randomised trials of interventions were identified and the authors concluded that some aspects of the conduct of the trial might affect a clinician\'s willingness to invite people to participate, for example, the way the clinician is invited to take part and the availability of support staff. In another Cochrane methodology review, Treweek et al. assessed strategies to improve recruitment to research studies (Treweek [@b163]), but recruitment to trials presents different challenges to participant engagement and follow-up. For example, strategies to market a trial and win over participants during the recruitment phase may be different to strategies to keep participants engaged in a trial (Francis [@b122]).

Many untested strategies are used by researchers to try to improve retention in randomised trials. Therefore, because loss to follow-up can compromise the validity of a trial\'s findings, delay results and, in some circumstances, increase the costs of the research, a systematic review is needed to assess the effect of strategies to improve retention in randomised trials.

Objectives
==========

To quantify the effect of strategies to improve retention in randomised trials.

To investigate if the effect varies by the type of strategy, trial setting and healthcare area.

Methods
=======

Criteria for considering studies for this review
------------------------------------------------

### Types of studies

We included completed randomised trials that compared strategies to increase retention embedded in host randomised trials (hereafter referred to as retention trials). The retention trials were embedded in real trials (host trials) and not hypothetical trials. The retention trials included at least one randomised comparison of two or more strategies to improve retention, or compared one or more strategies with no strategy. In anticipation of few trials, we included retention trials if they were randomised or quasi-randomised (e.g. had used alternation, date of birth or case record number as a method of allocating participants) (Lefebvre [@b137]).

Strategies to improve retention were designed for impact after participants were recruited and randomised to either the intervention or control group of the main and the retention trial. We included trials to increase response to postal and electronic questionnaire. We excluded trials to increase recruitment only. We excluded cohort studies with embedded randomised retention trials, which were the subject of a separate systematic review (Booker [@b107]).

### Types of data

We included randomised and quasi-randomised retention trials within the context of a host randomised trial with participants from any age, gender, ethnic, cultural, language and geographic groups. We included unpublished and published participant retention data from randomised trials addressing healthcare (including all disciplines and disease areas) and non-healthcare (education, social sciences) topics. We also included trials set in the community that were healthcare related.

### Types of methods

We considered any strategy aimed at increasing retention, directed towards the clinician, researcher or participant. We included strategies compared with each other or with usual study procedures. We also included trials with any combination of strategies to increase retention. Strategies could be participant or trial management focused and include any of the following:

strategies to motivate participants and clinicians (e.g. incentives or gifts);strategies to improve communication with participants or trial sites (e.g. enhanced letters);methodology strategies (e.g. shorter length of follow-up or variation in follow-up visit frequency);strategies to improve social support for participant retention.

### Types of outcome measures

#### Primary outcomes

We used retention (the proportion of participants retained) at the primary analysis point as defined in each individual retention trial as the primary outcome because it is easier to interpret than attrition/loss to follow-up (i.e. the proportion lost or not retained). In cases where the time point for measurement of the primary outcome was not predefined, we took the first time point reported for analysis. In most cases, this was final response. If retention at a number of time points was reported and no clear time point for the primary outcome for the retention trial was stated, we took data for the nearest time point to the intervention in the retention trial analyses.

#### Secondary outcomes

Retention of participants at secondary analysis points.

Search methods for identification of studies
--------------------------------------------

We designed a search strategy to identify published and unpublished randomised and quasi-randomised trials that assessed strategies to improve retention in randomised trials in healthcare, education and social science settings. We searched bibliographic databases for published trials and trial registers for trials that had not been fully published, or were unpublished or ongoing. We applied no language restrictions.

### Electronic searches

Each search comprised an established filter to identify randomised trials plus free-text terms and database subject headings relating to reducing loss to follow-up or increasing retention ([Appendix 1](#app1){ref-type="app"}). Electronic databases searched included:

the Cochrane Central Register of Controlled Trials (CENTRAL) (to May 2012);

PreMEDLINE (to April 2010);MEDLINE (1950 to May 2012) ([Appendix 2](#app2){ref-type="app"}), EMBASE (1980 to May 2012) ([Appendix 3](#app3){ref-type="app"}) and PsycINFO (1806 to May 2012) ([Appendix 4](#app4){ref-type="app"}), searched using an Ovid platform;Database of Abstracts of Reviews of Effects (DARE, in *The Cochrane Library* May 2012);CINAHL (Cumulative Index to Nursing and Allied Health; 1981 to May 2012) ([Appendix 5](#app5){ref-type="app"}), using the EBSCOHost platform;Campbell Collaboration\'s Social, Psychological, Educational and Criminological Trials Register (C2-SPECTR http://geb9101.gse.upenn.edu/: searched May 2009 (website no longer accessible)) ([Appendix 6](#app6){ref-type="app"});Education Resource Information Centre (ERIC) 1966 to May 2009) ([Appendix 7](#app7){ref-type="app"}), using Dialog Datastar.

### Searching other resources

We handsearched the reference lists of relevant publications and reviews to identify further trial reports (Horsley [@b131]) ([Appendix 8](#app8){ref-type="app"}). We also searched the abstracts of Society for Clinical Trials (SCT) meetings from 1980 to 2012, the Current Controlled Trials *meta*Register of Controlled Trials (*m*RCT) (<http://www.controlled-trials.com/mrct>), the Cochrane Methodology Register (in *The Cochrane Library* to April 2012) and the World Health Organization (WHO) trials platform (<http://apps.who.int/trialsearch>). We conducted a survey of Clinical Trial Units in the UK to identify further eligible trials not identified through other sources and the review was presented at the Society for Clinical Trials 31st Conference in Baltimore, USA in May 2010 and advertised on the Conference notice board with the aim of identifying potentially eligible trials from outside the UK.

Data collection and analysis
----------------------------

### Selection of studies

One review author (VB) selected potentially eligible trials from the titles and abstracts retrieved by the searches, using a predesigned study eligibility screening form. We were over inclusive when screening, 0.7% (168/24,304) of records identified were sent for screening to a second review author (GR), which is 23% (168/735) of all potentially eligible records identified. We obtained full-text papers and two review authors (VB, GR) reviewed potentially eligible trials for inclusion. We contacted study authors for electronic copies of papers that we could not access through library sources. We were able to obtain copies of all the potentially eligible papers that we wanted to screen. We resolved disagreements by discussion with a third review author (SS). When necessary, we sought information from the original investigators for potentially eligible trials where we wished to clarify eligibility.

### Data extraction and management

One review author (VB) extracted data from eligible retention trial and associated host trial papers and a second review author (JT) checked the entries. We reached consensus on any disparities by discussion with a third review author (SS). Data extracted for the host trial were aim, setting, disease area, comparators, primary outcome, sample size calculation, inclusion exclusion criteria, sequence generation and allocation concealment, and numbers randomised to each group. For the embedded retention trial, we extracted data for onset in relation to the host trial, source of the sample, aim, primary outcome and type of follow-up. The retention strategy details included type, frequency and timing of administration method of randomisation, numbers randomised, included and retained at primary analysis, and data required for the risk of bias assessment.

### Assessment of risk of bias in included studies

To assess the validity of each retention trial we judged them against the four domains of the Cochrane \'Risk of bias\' tool (Higgins [@b128]). To assess selection bias, we recorded how the allocation sequence was generated at study level and the methods used to conceal the allocation. We assessed performance bias by recording methods used to blind participants if considered appropriate to do so. For some interventions, participants could not be blinded to the intervention (e.g. where vouchers, cash or gifts were administered). However, in these cases, study personnel could be blinded to the allocation if administration of the intervention was carried out by someone unaware of the allocation.

As retention is the subject of our review, and retention of participants is the primary outcome, attrition from the trials does not constitute a bias and has not been included in the \'Risk of bias\' tables. We assessed each included retention trial for selective outcome reporting by recording the primary outcome for the trial and the outcomes for which results were reported. A judgement was made about each trial for each risk of bias domain assessed. For completed host trials (within which retention trials were embedded), we only assessed sequence generation and allocation concealment, in order to ensure the host trial was randomised.

### Measures of the effect of the methods

We calculated risk ratios (RR) and their 95% confidence intervals (CI) for retention to determine the effect of strategies on this outcome.

### Unit of analysis issues

For retention trials that randomised individuals and clusters, the unit of analysis was the participant. For cluster randomised trials that ignored clustering in the analysis, we inflated the standard errors (SE) to avoid overprecise estimates of effect as follows (Higgins [@b129]).

We calculated the RR, 95% CI and SE based on participants in the usual way (i.e. ignoring clustering).This standard error was then inflated using the design effect to get an adjusted SE: adjusted SE = SE X√ design effect. With the design effect calculated as follows: design effect = 1 + (M - 1) ICC where M = mean cluster size, ICC = the intracluster correlation coefficient.Where published ICCs were not available, we used the mean ICC from appropriate external estimates for Land [@b34]. This was the mean of estimates for the return of EuroQol questionnaires (ICC = 0.054) from a source recommended by the *Cochrane Handbook for Systematic Reviews of Interventions* (Section 16.3.4) (Higgins [@b129]) and <http://www.abdn.ac.uk/hsru/documents/iccs-web.xls> (last accessed 27 September 2013).We entered the effect estimate and the new updated SE into Review Manager 5 using the generic inverse variance (RevMan [@b151]).

Where the number of participants randomised was not clearly stated in the included study report, we contacted the study authors for this information.

### Dealing with missing data

We contacted study authors for data for the risk of bias assessment, numbers randomised to each group and numbers retained in each group at the primary endpoint. We described outcomes with insufficient data qualitatively. For time-to-event outcomes, we used the time point of the host study primary outcome, taking account of censoring if necessary and if the data were available.

### Assessment of heterogeneity

We measured heterogeneity of the intervention effect using the Chi^2^ statistic at a significance level of 0.10 and the I^2^ statistic (Higgins [@b127]), and explored through subgroup analyses.

### Assessment of reporting biases

We would have investigated reporting bias using tests for funnel plot asymmetry if sufficient data had been available (Egger [@b119]; Sterne [@b158]).

### Data synthesis

If there was no substantial heterogeneity, we pooled RRs using the fixed-effect model. If heterogeneity was detected and could not be explained by subgroup or sensitivity analyses, we used the random-effects model or did not pool results.

For factorial trials (Sharp [@b60], Kenton [@b22]), all main effects were included as separate trial comparisons if they addressed different categories of strategies. Where the main effects addressed two or more strategies within the same category (e.g. Bowen [@b9]), we combined the relevant intervention groups and compared them with the control group. We also compared each intervention group with the control group, as separate trial comparisons, in exploratory analyses. For one 2 x 2 x 2 x 2 factorial trial (Renfroe [@b52]), the numbers randomised for each group were not available at the time of analysis so comparison groups were collapsed as far as possible and then treated as separate trial comparisons in the appropriate analyses. For two three-armed trials that compared two similar intervention groups with one control group, we combined the intervention groups and compared it with the control group for the main analyses (Bauer [@b6], Khadjesari [@b29]). We also compared each intervention group as separate trial comparisons in exploratory analyses.

These approaches allowed full exploration of the data and also avoided double counting and over-precise pooled estimates of effect in our main analyses. However, this also meant that there were occasionally a greater number of trial comparisons than trials.

Computations for the absolute benefits of effective strategies on questionnaire response and trial retention were based on absolute risk reductions derived from meta-analysis RRs (*Cochrane Handbook for Systematic Reviews of Interventions*, Section 12.5.4.2: [@b155]).

### Subgroup analysis and investigation of heterogeneity

To explore the effect of different strategies on trial retention, we planned the following subgroup analyses by the type of strategy used in included retention trials.

Whether the strategy was compared with usual follow-up or other strategies.Whether in healthcare or non-healthcare settings.Whether assessment of retention was immediate or longer term (e.g. if a response to a questionnaire was expected immediately or at later time points).Whether the strategy was participant or management focused.

However, we identified such a diversity of retention trials and interventions that these analyses were inappropriate or not possible. Therefore, different types of strategies were analysed separately and new subgroups were defined within these before we conducted the analyses.

#### (a) Incentives

We subgrouped retention trials or trial comparisons evaluating the addition of an incentive strategy versus none as follows for analysis.

Monetary incentives given upfront, defined as money given to the trial participant prior to data collection in cheque, cash or voucher format.Non-monetary incentives, defined as gifts, for example, pens or certificates.Offers of monetary incentives after data collection, defined as a promise of the incentive after return of outcome data through attendance for scheduled follow-up or receipt of follow-up questionnaires.Offers of non-monetary incentives defined as a promise of the non-monetary incentive after return of outcome data through attendance for scheduled follow-up or receipt of follow-up questionnaires.

We subgrouped retention trials or trial comparisons comparing different values of monetary incentives into:

those offering incentives;those both giving and offering an incentive for any subsequent data (e.g. sending GBP5 with a questionnaire with an offer of GBP5 if the questionnaire is returned).

We analysed retention trials evaluating the addition of a monetary incentive versus either an offer of a monetary incentive or follow-up by telephone separately.

#### (b) Communication

We grouped retention trials or trial comparisons of the effect of different communication strategies into letter, post and reminder strategies for analysis as follows.

Enhanced versus standard cover letter.Total design method versus standard postal communication strategy.Priority versus regular post.Additional reminders versus usual reminders to trial sites.Additional reminders versus usual follow-up to trial participants.Early versus late administration of questionnaire (i.e. sending questionnaires two to three weeks after a follow-up visit versus one to four months after a follow-up visit).Recorded delivery versus telephone reminder.

#### (c) Questionnaire structure

We subgrouped trials of questionnaire strategies into length of questionnaire, clarity of meaning, order of questions and layout as follows.

Short versus long questionnaire.Long and clear questionnaire versus short and condensed questionnaire.Medical condition questions first versus generic questions first.Relevance of questionnaires: alcohol versus mental health questionnaires.

There were no subgroups for behavioural, case management and methodology retention trials.

Our analyses focused on the primary endpoint of retention. We initially pooled retention trials within subgroups using the fixed-effect model and quantified heterogeneity. We assessed whether these subgroups had a differential impact on retention using the test for interaction. We did not pool trials if results were inconsistent or heterogeneity was excessive.

### Sensitivity analysis

To assess the robustness of the results we planned sensitivity analyses that excluded quasi-randomised retention trials.

Results
=======

Description of studies
----------------------

The studies are described in the Characteristics of included studies, Characteristics of studies awaiting classification, and Characteristics of excluded studies tables.

### Results of the search

We identified 24,304 abstracts, titles and other records from database searches to May 2012, handsearches of reviews, lists of references in included papers, SCT conference abstracts (to 2012), personal contact with trialists, and the survey of UK Clinical Trials Units (Figure [1](#fig01){ref-type="fig"}). We screened 735 full-text papers, reports and manuscripts for eligible studies. Of 68 potentially eligible studies, we found 30 to be subsequently ineligible. This left 38 retention trials for inclusion in the review. The retention trials were embedded in real trials (host trials). We identified 11retention trials from CENTRAL, MEDLINE and CINAHL; 14 from handsearching reviews, conference abstracts, and references lists of eligible papers; and 13 through personal communications or correspondence with clinical trials units. We evaluated six broad types of strategy to improve retention in randomised trials. Most strategies were targeted at increasing questionnaire response. The strategies used for this were incentives, communication, methodology and questionnaire design strategies. There was minimal evidence for the use of behavioural and case management strategies to improve retention.

![Attrition study flow diagram.](MR000032-0001-f1){#fig01}

### Included studies

Of the 38 eligible retention trials, 28 were published in full, one as an abstract (Kenton [@b22]), and one as part of a PhD thesis (Nakash [@b50]). Four retention trial publications contained two trials each (Khadjesari [@b27]; McCambridge [@b40]; McColl [@b47]; Severi [@b56]). Eight retention trials are unpublished as of June 2013 (Bailey [@b3]; Bailey [@b4]; Edwards [@b17]; Land [@b34]; Letley [@b36]; [@b37]; Marson [@b39]; Svoboda [@b70]).

#### Host trials

Twenty-two host trials included a single retention trial (AVID [@b106]; Boyd [@b108]; Chaffin [@b12]; Cooke [@b110] Cox [@b15]; Gail [@b125]; Dennis [@b114]; Hughes [@b132]; International [@b133]; Kenyon [@b134]; Lamb [@b135]; Leigh [@b138]; Marson [@b141]; Omenn [@b145]; Porterhouse [@b147]; Rothert [@b153]; Tai [@b159] Tilbrook [@b160]; TOMBOLA [@b161]; TOMBOLA [@b162]; UK [@b164]). Two host trials from this group were unpublished (for the retention trials by Ashby [@b1] and Land [@b34]).

The other host trials included multiple retention trials (one unpublished for the retention trials by Bailey [@b3] and Bailey [@b4]). Two retention trials (Ford [@b18]; Subar [@b68]) were embedded in the US-based Prostate, Lung, Colorectal, Ovarian (PLCO) screening trial of Prorok [@b148]; two (Avenell [@b2]; [@b37]) in the RECORD fracture prevention trial (RECORD [@b149]); two (Edwards [@b17]; Svoboda [@b70]) in the CRASH trial (CRASH [@b111]); four (Khadjesari [@b29]; Khadjesari [@b33]; McCambridge [@b41]; McCambridge [@b44]) in the Down your Drink Trial (Murray [@b143]); two (Bailey [@b3]; Bailey [@b4]) in a feasibility study for the Sex unzipped website (unpublished); two (Severi [@b57]; Severi [@b58]) in the Text to Stop smoking cessation trial (Free [@b123]); and two (McColl [@b48]; McColl [@b49]) in the COGENT trial (Eccles [@b117]).

#### Participants and settings

Included retention trials were conducted in a broad spectrum of clinical conditions and geographical settings (see [Appendix 9](#app9){ref-type="app"}). Eight included retention trials were embedded in trials for the treatment of alcohol and smoking dependency (Bauer [@b6]; Hughes [@b20]; Khadjesari [@b29]; Khadjesari [@b33]; McCambridge [@b41]; McCambridge [@b44]; Severi [@b57]; Severi [@b58]), and four in trials investigating treatments for injuries (Edwards [@b17]; Gates [@b19]; Nakash [@b50]; Svoboda [@b70]). Six retention trials were set in treatment trials for cancer, cardiovascular disease, epilepsy and back pain (Dorman [@b16]; Land [@b34]; Letley [@b36]; Man [@b38]; Marson [@b39]; Renfroe [@b52]), and four were embedded in screening trials for cancer, postnatal depression, and elderly diseases (Ford [@b18]; Kenton [@b22]; Sharp [@b60]; Subar [@b68]). Seven retention trials were embedded in prevention trials, which included two cancer prevention trials for lung and breast cancer (Bowen [@b9]; Sutherland [@b69]), one migraine prevention trial (Ashby [@b1]), and three fracture prevention trials (Avenell [@b2]; Cockayne [@b13]; [@b37]). Four retention trials were conducted in clinical management trials for orthopaedics, asthma, diabetes and angina (Leigh [@b35]; McColl [@b48]; McColl [@b49]; Tai [@b71]). Six retention trials were conducted in other areas: exercise (Cox [@b15]), parenting (Chaffin [@b12]), weight management (Couper [@b14]), neonatal medicine (Kenyon [@b26]), and sexual health promotion (Bailey [@b3]; Bailey [@b4]).

Twenty-five retention trials were UK based, nine were USA based and two were set in Canada. The remainder were set in Czech Republic and Australia (see Characteristics of included studies table).

Retention trials were embedded in host trials that recruited participants from different settings. Five trials recruited participants directly from the community. Sixteen trials were conducted through secondary care facilities. One trial recruited participants through a combination of state workers compensation programmes, occupational and physician clinic, a surveillance programme and union records. Six UK trials recruited solely through general practitioner (GP) practices and two used a combination of recruitment through GP practices and the media. Seven trials recruited participants via the Internet, six of these were UK based and the other was US based. For one US-based smoking cessation trial, it was unclear how participants were recruited (see Characteristics of included studies table).

#### Design of included retention trials

One trial was hosted in a clustered randomised trial and used this design to evaluate a strategy to improve retention (Land [@b34]). Four retention trials used different factorial designs (Bowen [@b9]; Kenton [@b22]; Renfroe [@b52]; Sharp [@b60]). There was also one three-armed trial (Bauer [@b6]), and three four-armed trials (Khadjesari [@b29]; McCambridge [@b41]; McCambridge [@b44]).

Five trials used quasi-randomisation to allocate participants (Bowen [@b9]; Ford [@b18]; Gates [@b19]; McColl [@b48]; McColl [@b49]). Two used participant identification numbers (Ford [@b18]; Gates [@b19]), and two allocated the first half of a simple random sample of participants to receive one version of a questionnaire, while the remaining half was allocated to a second version (McColl [@b48]; McColl [@b49]). One retention trial used day of clinic visit to allocate participants (Bowen [@b9]).

All trials targeted individual trial participants, except one that targeted trial sites (Land [@b34]).

We recorded the timing of randomisation in the host trial versus the timing of randomisation in the retention trial. Four trials commenced during a randomised pilot study for the host trial (Khadjesari [@b29]; Letley [@b36]; McCambridge [@b41]; Sutherland [@b69]). One study started before the host trial (Chaffin [@b12]). Twenty-nine trials commenced during follow-up for the host trial (Ashby [@b1]; Avenell [@b2]; Bailey [@b3]; Bailey [@b4]; Bowen [@b9]; Cockayne [@b13]; Couper [@b14]; Cox [@b15]; Dorman [@b16]; Edwards [@b17]; Ford [@b18]; Gates [@b19]; Khadjesari [@b33]; Land [@b34]; Leigh [@b35]; [@b37]; Man [@b38]; Marson [@b39]; McCambridge [@b44]; McColl [@b48]; McColl [@b49]; Nakash [@b50]; Renfroe [@b52]; Severi [@b57]; Severi [@b58]; Sharp [@b60]; Subar [@b68]; Svoboda [@b70]; Tai [@b71]). For one trial, it was unclear when the retention trial started in relation to the host trial (Kenton [@b22]). Three retention trials started after the host trial had finished (Bauer [@b6]; Hughes [@b20]; Kenyon [@b26]): Kenyon [@b26] followed-up seven-year-old children of mothers enrolled in the ORACLE trial (Kenyon [@b134]), Bauer [@b6] followed up participants in the COMMIT smoking cessation trial (Gail [@b125]), eight years after the original trial was completed and Hughes [@b20] followed up participants in a smoking cessation trial six months after that study finished (Hughes [@b132]).

#### Strategies to improve retention

Retention in trials and response to questionnaires were the outcomes measured for all included trials. The included trials evaluated six different types of strategies to improve response or retention. Incentives, communication strategies, variation in questionnaire design, methodology strategies, and combinations of communication and incentive strategies evaluated improving response to postal and electronic questionnaires. Behavioural strategies, case management and some non-monetary incentives were used to encourage participants to return to trial sites for follow-up visits. Each type of strategy is described separately below.

#### Outcome measures in the included trials

Thirty-four retention trials measured response to questionnaires. Among these, the questionnaires were by post in 26 trials, electronically in four and one was done by interview. For another three retention trials, response was return of biomedical kits or biomedical kits plus a questionnaire (see Characteristics of included studies table).

Four included trials measured the number of participants remaining in the trial (Bowen [@b9]; Chaffin [@b12]; Cox [@b15]; Ford [@b18])

Ten included trials specified that their primary outcome was questionnaire response at a particular time point: McCambridge [@b41] measured response at one and three months, McCambridge [@b44] measured response at three and 12 months, and Khadjesari [@b29] and Khadjesari [@b33] measured response within 40 days of the first reminder. For Severi [@b57], the primary outcome was completed follow-up at 30 weeks from randomisation, Severi [@b58] used return of specimens one month after a telephone call, Avenell [@b2] used retention at one year measured by questionnaire return but also reported retention at four and eight months. Cockayne [@b13] and Sharp [@b60] had final follow-up questionnaire response at any time as their primary outcome.

Two included trials reported questionnaire response at one time point only but without specifying that this was the primary outcome for the trial (Edwards [@b17]; Svoboda [@b70]). These trials measured response at three months from the questionnaire being sent. One trial reported trial retention at one time point only (three years) but without specifying that this was the primary outcome for the trial (Ford [@b18]). This was measured as completing the next cancer screening in a cancer screening trial. In each of these three trials, we used these data for analyses.

Two trials recorded questionnaire response at two time points without stating which was the primary outcome (Dorman [@b16]; Gates [@b19]). One trial recorded retention at two time points without stating which was the primary outcome (Cox [@b15]). We used data for response/retention after the first contact with respondents as the primary outcome for analyses. One trial reported response at three time points (4 weeks, 12 weeks and 9 months), which were all stated as the primary outcome (Nakash [@b50]). We used the data for week four in our main analysis.

Five trials reported data in survival curves. For these, we used the final analysis point (Ashby [@b1]; Bowen [@b9]; Chaffin [@b12]; Land [@b34]; Sutherland [@b69]). Authors confirmed data when it had been extracted. Fifteen trials reported the number of questionnaires returned with no time point specified (Bauer [@b6]; Couper [@b14]; Hughes [@b20]; Kenton [@b22]; Kenyon [@b26]; Leigh [@b35]; Letley [@b36]; [@b37]; Man [@b38]; Marson [@b39]; McColl [@b48]; McColl [@b49]; Renfroe [@b52]; Subar [@b68]; Tai [@b71]).

#### Addition of incentive versus none

There were 14 retention trials of incentives and 19 trial comparisons ([Table 1](#tbl1){ref-type="table"}). Thirteen trials were aimed at improving questionnaire response in trials and one trial was aimed at improving return for follow-up at trial site (Bowen [@b9]). The different incentive strategies aimed at improving questionnaire response were vouchers, cash, a charity donation, entry to prize draws, cheques, a certificate of appreciation and offers of study results. Incentive strategies aimed at improving retention were: certificates of appreciation and lapel pins. The value of incentives used in UK evaluations ranged from GBP5 to GBP20 and were in cash, cheque or voucher format. The value of incentives used in US-based studies was USD2 to USD10. For offers of entries into prize draws, the values were higher, ranging from GBP25 to GBP250 for UK prize draws and USD50 for US-based prize draws. One trial evaluated giving a monetary incentive with a promise of a further incentive for return of trial data (Bailey [@b4]).

###### 

Trials evaluating incentive strategies

  Trial or trial comparison                                   Incentive groups                                                                                     Control group                                               Outcome type
  ----------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------
  **Addition of incentive vs. none**                                                                                                                                                                                           
                                                                                                                                                                                                                               
  Bauer [@b6]                                                 a\) USD10 cheque b) USD2 cheque Arms combined for main analysis                                      No incentive                                                DNA specimen kit return plus postal questionnaire response
                                                                                                                                                                                                                               
  Gates [@b19]                                                GBP5 voucher                                                                                         No incentive                                                Postal questionnaire response
                                                                                                                                                                                                                               
  Kenyon [@b26]                                               GBP5 voucher                                                                                         No incentive                                                Postal questionnaire response
                                                                                                                                                                                                                               
  Khadjesari [@b30]                                           a\) Offer GBP5 voucher c) Offer of entry into GBP250 prize draw, groups combined for main analysis   No incentive                                                Internet-based questionnaire response
                                                                                                                                                                                                                               
  Khadjesari [@b33]                                           Offer of GBP10 Amazon.co.uk voucher                                                                  No incentive                                                Internet-based questionnaire response
                                                                                                                                                                                                                               
  Bowen [@b9]                                                 a\) Certificate b) Pin c) Pin and certificate groups combined for main analysis                      No incentive                                                Participants retention
                                                                                                                                                                                                                               
  Renfroe [@b51]                                              Certificate of appreciation                                                                          No certificate of appreciation                              Postal questionnaire response
                                                                                                                                                                                                                               
  Sharp [@b59]                                                Pen                                                                                                  No pen                                                      Postal questionnaire response
                                                                                                                                                                                                                               
  Sharp [@b61]                                                Pen                                                                                                  No pen                                                      Postal questionnaire response
                                                                                                                                                                                                                               
  Sharp [@b62]                                                Pen                                                                                                  No pen                                                      Postal questionnaire response
                                                                                                                                                                                                                               
  Sharp [@b63]                                                Pen                                                                                                  No pen                                                      Postal questionnaire response
                                                                                                                                                                                                                               
  Cockayne [@b13]                                             Offer of study results                                                                               No offer                                                    Postal questionnaire response
                                                                                                                                                                                                                               
  Hughes [@b20]                                               Offer of free reprint of results                                                                     No offer                                                    Postal questionnaire response
                                                                                                                                                                                                                               
  Khadjesari [@b31]                                           Offer of GBP5 charity donation                                                                       No offer                                                    Internet-based questionnaire response
                                                                                                                                                                                                                               
  **Addition of monetary incentive to both groups**                                                                                                                                                                            
                                                                                                                                                                                                                               
  Bailey [@b3] unpublished                                    Offer of GBP20 shopping voucher                                                                      Offer of GBP10 shopping voucher                             Postal questionnaire response
                                                                                                                                                                                                                               
  Bailey [@b4] unpublished                                    Shopping voucher: GBP10 in advance and GBP10 on data return                                          Shopping voucher: GBP5 in advance and GBP5 on data return   Questionnaire response and chlamydia kit return
                                                                                                                                                                                                                               
  **Addition of monetary incentive vs. offer of incentive**                                                                                                                                                                    
                                                                                                                                                                                                                               
  Kenton [@b21]                                               USD2 coin                                                                                            Draw for USD50 gift voucher                                 Postal questionnaire response
                                                                                                                                                                                                                               
  Kenton [@b23]                                               USD2 coin                                                                                            Draw for USD50 gift voucher                                 Postal questionnaire response
                                                                                                                                                                                                                               
  **Offer of prize draw vs. no offer**                                                                                                                                                                                         
                                                                                                                                                                                                                               
  Leigh [@b35]                                                Aware of monthly prize draw of GBP25 gift voucher                                                    No offer of draw                                            Postal questionnaire response

##### Communication strategies

There were 14 retention trials of communication strategies to improve response to postal questionnaires or return of biomedical test kits, or both, in randomised trials. There were 20 trial comparisons ([Table 2](#tbl2){ref-type="table"}). Strategies evaluated were: enhanced letters, additional reminders to participants, priority mailing of questionnaires, time of questionnaire administration, telephone contact and reminders to trial sites of upcoming assessments. One trial used a combination of postal communication strategies known as the total design method (TDM) (Sutherland [@b69]). This included sending letters in a white envelope with a hospital logo and commemorative stamp, a hand-signed letter on headed notepaper, with a reply self addressed stamped envelope, enclosing the contents. Follow-up was with a postcard sent after seven days followed by two reminder letters. This was compared with a customary method for postal follow-up. One trial evaluated the addition of an electronic SMS (short message service) text reminder on the day participants were due to receive their postal questionnaire (Man [@b38]).

###### 

Trials evaluating communication strategies

  Trial or trial comparison                               Communication strategy                                                                    Control arm                                                     Outcome type
  ------------------------------------------------------- ----------------------------------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------
  **Enhanced letter vs. standard letter**                                                                                                                                                                           
                                                                                                                                                                                                                    
  Renfroe [@b54]                                          Cover letter signed by physician                                                          Cover letter signed by co-ordinator                             Postal questionnaire response
                                                                                                                                                                                                                    
  Marson [@b39]                                           Letter explaining the approximate length of time to complete questionnaire                Standard letter                                                 Postal questionnaire response
                                                                                                                                                                                                                    
  **Total design method vs. customary method**                                                                                                                                                                      
                                                                                                                                                                                                                    
  Sutherland [@b69]                                       Total design method for postal follow-up                                                  Standard method for postal follow-up                            Postal questionnaire response
                                                                                                                                                                                                                    
  **Priority vs. regular post**                                                                                                                                                                                     
                                                                                                                                                                                                                    
  Renfroe [@b53]                                          Express delivery                                                                          Standard delivery                                               Postal questionnaire response
                                                                                                                                                                                                                    
  Sharp [@b64]                                            Despatch first-class stamp                                                                Despatch second-class stamp                                     Postal questionnaire response
                                                                                                                                                                                                                    
  Sharp [@b65]                                            Despatch first-class stamp                                                                Despatch second-class stamp                                     Postal questionnaire response
                                                                                                                                                                                                                    
  Sharp [@b66]                                            Second-class return envelope                                                              Free post return envelope                                       Postal questionnaire response
                                                                                                                                                                                                                    
  Sharp [@b67]                                            Second-class return envelope                                                              Free post return envelope                                       Postal questionnaire response
                                                                                                                                                                                                                    
  Kenton [@b24]                                           Priority mail                                                                             Standard mail                                                   Postal questionnaire response
                                                                                                                                                                                                                    
  Kenton [@b25]                                           Priority mail                                                                             Standard mail                                                   Postal questionnaire response
                                                                                                                                                                                                                    
  **Additional reminder vs. usual follow-up**                                                                                                                                                                       
                                                                                                                                                                                                                    
  Ashby [@b1]                                             Electronic reminder                                                                       No electronic reminder                                          Postal questionnaire response
                                                                                                                                                                                                                    
  [@b37] unpublished                                      Telephone reminder                                                                        No telephone reminder                                           Postal questionnaire response
                                                                                                                                                                                                                    
  Nakash [@b50]                                           Trial calendar given at recruitment with questionnaire due dates                          No calendar                                                     Postal questionnaire response
                                                                                                                                                                                                                    
  Severi [@b57]                                           Text message and fridge magnet both emphasising social benefits of study participation.   Text message reminder sent 3 days after questionnaire           Postal questionnaire response
                                                                                                                                                                                                                    
  Severi [@b58]                                           Telephone reminder from principle investigator                                            Standard procedures.                                            Return of cotinine samples
                                                                                                                                                                                                                    
  Man [@b38]                                              SMS text message as follow-up questionnaire sent out                                      No SMS text message                                             Postal questionnaire response
                                                                                                                                                                                                                    
  **Additional trial site reminder vs. usual reminder**                                                                                                                                                             
                                                                                                                                                                                                                    
  Land [@b34]                                             Prospective monthly reminder of upcoming assessments to trial sites                       No extra reminder to trial sites                                Postal questionnaire response
                                                                                                                                                                                                                    
  **Early vs. late administration of questionnaire**                                                                                                                                                                
                                                                                                                                                                                                                    
  Renfroe [@b55]                                          Questionnaire sent 2-3 weeks after last AVID follow-up visit                              Questionnaire sent 1-4 months after last AVID follow-up visit   Postal questionnaire response
                                                                                                                                                                                                                    
  **Recorded delivery vs. telephone reminder**                                                                                                                                                                      
                                                                                                                                                                                                                    
  Tai [@b71]                                              Recorded delivery reminder                                                                Telephone reminder                                              Postal questionnaire response
                                                                                                                                                                                                                    
  **Addition telephone follow-up vs. incentive**                                                                                                                                                                    
                                                                                                                                                                                                                    
  Couper [@b14]                                           Telephone survey by trained interviewer                                                   Postal questionnaire and USD5 bill                              Post and questionnaire response

AVID: Antiarrhythmics Versus Implantable Defibrillators; SMS: short message service.

Five trials evaluated a combination of communication strategies and incentives to improve retention from randomised trials (Couper [@b14]; Kenton [@b22]; Renfroe [@b52]; Sharp [@b60]). The communication strategies were; first- and second-class outward post (Kenton [@b22]; Renfroe [@b53]; Sharp [@b60]), stamped and business reply envelopes (Sharp [@b60]), letters signed by different study personnel (Renfroe [@b54]), letters posted at different times (Renfroe [@b55]), text messages (Man [@b38]; Severi [@b57]), and a telephone survey (Couper [@b14]).

##### Questionnaire format

The effect of a change in questionnaire format on response to randomised trial questionnaires was evaluated in eight trials with 10 comparisons ([Table 3](#tbl3){ref-type="table"}). Formats evaluated were questionnaire length: short versus long (Dorman [@b16]; Edwards [@b17]; McCambridge [@b43]; McCambridge [@b46]; Svoboda [@b70]), long and clear versus short and condensed (Subar [@b68]), and the order of questions (Letley [@b36]; McColl [@b48]; McColl [@b49]).

###### 

Trials evaluating new questionnaire strategies

  Trial or trial comparison                    Questionnaire strategy                                          Control arm                                               Outcome type
  -------------------------------------------- --------------------------------------------------------------- --------------------------------------------------------- -----------------------------------------------------
  **Short vs. long**                                                                                                                                                     
                                                                                                                                                                         
  Dorman [@b16]                                Short EuroQol                                                   Long SF-36 questionnaire.                                 Postal questionnaire response
                                                                                                                                                                         
  Edwards [@b17] unpublished                   1-page, 7-question functional dependence questionnaire          3-page, 16-question functional dependence questionnaire   Postal questionnaire response
                                                                                                                                                                         
  Svoboda [@b70] unpublished                   1-page, 7-question functional dependence questionnaire          3-page, 16-question functional dependence questionnaire   Postal questionnaire response
                                                                                                                                                                         
  McCambridge [@b43]                           AUDIT Short + LDQ                                               APQ                                                       Internet-based questionnaire response
                                                                                                                                                                         
  McCambridge [@b46]                           AUDIT Short + LDQ                                               APQ                                                       Internet-based questionnaire response
                                                                                                                                                                         
  **Long and clear vs. short and condensed**                                                                                                                             
                                                                                                                                                                         
  Subar [@b68]                                 DHQ (36-page food frequency questionnaire)                      PLCO (16-page food frequency questionnaire)               Postal questionnaire response and onsite completion
                                                                                                                                                                         
  **Question order**                                                                                                                                                     
                                                                                                                                                                         
  McColl [@b48]                                Asthma condition-specific questions first followed by generic   Generic questions followed by condition specific          Postal questionnaire response
                                                                                                                                                                         
  McColl [@b49]                                Angina condition-specific questions followed by generic         Generic questions followed by condition specific          Postal questionnaire response
                                                                                                                                                                         
  Letley [@b36] unpublished                    RDQ at front and SF-36 at back                                  SF-36 at front RDQ at back                                Postal questionnaire response
                                                                                                                                                                         
  **Relevance of questionnaire**                                                                                                                                         
                                                                                                                                                                         
  McCambridge [@b42]                           APQ23 items                                                     CORE-OM Mental health assessment 23/34 items              Internet-based questionnaire response
                                                                                                                                                                         
  McCambridge [@b45]                           AUDIT Short + LDQ                                               CORE-OM Mental health assessment 10 items                 Internet-based questionnaire response

APQ: Alcohol Problems Questionnaire; AUDIT: Alcohol Use Disorders Identification Test; LDQ Leeds Dependency Questionnaire; PLCO: Prostate, Lung, Colorectal, Ovarian; SF-36: Short Form 36 item.

Two further included trials evaluated the effect of the relevance of a questionnaire on response (McCambridge [@b42]; McCambridge [@b45]). Relevance was defined as assessing alcohol problems rather than mental health in the context of an Internet-based intervention for hazardous drinkers (McCambridge [@b41]; McCambridge [@b44]).

##### Behavioural strategies

There were two trials of behavioural strategies used for retention in randomised trials (Chaffin [@b12]; Cox [@b15]). Cox [@b15] compared motivational workshops versus information sheets. Chaffin [@b12] compared self motivation orientation versus standard information in the context of a parenting programme. In this case, the retention trial was run prior to the host trial with the intention of improving retention in the subsequent parenting programme evaluation trial. The analysis was based on the number eligible for inclusion in the primary analyses for the subsequent parenting programme because we do not know the allocation of those who dropped out between first and second randomisations. Complete time-to-event data were not available for Chaffin [@b12], but, as only two participants were censored in the analysis, this is unlikely to have biased the results.

#### Case management

One retention trial evaluated the effect of intensive case management procedures on retention of African American male participants in a cancer screening trial (Ford [@b18]).

#### Methodology strategies

One included trial used a trial design where people knew which treatment they received. The trial compared questionnaire response in an open versus blind trial (Avenell [@b2]).

#### Studies excluded from analyses

Two eligible trials could not be included in the analysis (Leigh [@b35]; Letley [@b36]). Host trial participants in the retention trial by Leigh [@b35] were divided into two groups; one randomised, the other determined by preference of the referring primary care practitioner. The author confirmed that participants in the retention trial were from both randomised and non-randomised groups of the host trial and that these could not be separated.

One recently completed, unpublished trial that is not included in the review examined the effect of newsletters on retention ([@b103]). This trial will be included in the review update.

### Excluded studies

See Characteristics of excluded studies table.

We excluded trials because they were either part of a non-randomised host study, or they were not a randomised retention trial, or the primary outcome was type of data item missingness. Other excluded trials were aimed at increasing treatment compliance or baseline questionnaire response. We contacted investigators to confirm aspects of eligibility.

Risk of bias in included studies
--------------------------------

See Characteristics of included studies.

### Allocation

All included retention trials reported that participants were randomly allocated to groups for comparison. Twenty-four included trials described adequate sequence generation by a computerised random number generator, block randomisation or use of a table of random numbers table (Avenell [@b2]; Bailey [@b3]; Bailey [@b4]; Bowen [@b9]; Chaffin [@b12]; Cockayne [@b13]; Cox [@b15]; Hughes [@b20]; Kenyon [@b26]; Khadjesari [@b29]; Khadjesari [@b33]; Land [@b34]; Leigh [@b35]; Letley [@b36]; [@b37]; Man [@b38]; Marson [@b39]; McCambridge [@b41]; McCambridge [@b44]; Nakash [@b50]; Renfroe [@b52]; Severi [@b57]; Severi [@b58]; Sutherland [@b69]). There was insufficient information about the sequence generation for 10 included trials, these were all described as randomised in the retention trial publications (Ashby [@b1]; Bauer [@b6]; Couper [@b14]; Dorman [@b16]; Edwards [@b17]; Kenton [@b22]; Sharp [@b60]; Subar [@b68]; Svoboda [@b70]; Tai [@b71]). Five included trials used quasi-randomisation to allocate participants (Bowen [@b9]; Ford [@b18]; Gates [@b19]; McColl [@b48]; McColl [@b49]).

Several methods were used to avoid foreseen allocation of participants; sequence generation by a trial statistician and implemented by a trial manager; sequence generation by an independent researcher, a central randomisation service, or by a nurse using a preprogrammed computer; or allocation by sealed envelopes or sequentially numbered packs. Fifteen trials reported both adequate sequence generation and allocation concealment (Avenell [@b2]; Bailey [@b3]; Bailey [@b4]; Cockayne [@b13]; Cox [@b15]; Hughes [@b20]; Kenyon [@b26]; Khadjesari [@b29]; Khadjesari [@b33]; Letley [@b36]; [@b37]; Man [@b38]; McCambridge [@b41]; McCambridge [@b44]; Nakash [@b50]).

### Blinding

Blinding of participants was generally not possible in included trials. For example, it is not possible to blind participants to the following strategies to increase trial retention or response to questionnaires: incentive or offer of incentive, behavioural (Cox [@b15]), or case management strategies (Ford [@b18]), different types of communication strategies, or questionnaire format strategies. In a number of trials, authors mentioned that participants were aware of the intervention they were getting but were unaware that this was being evaluated (Bowen [@b9]; Chaffin [@b12]; Kenton [@b22]; Kenyon [@b26]; Leigh [@b35]; [@b37]; Marson [@b39]; McColl [@b48]; McColl [@b49]). For other trials, blinding of participants or study personnel to the outcome or intervention was not reported. For one trial, a judgement about blinding was not applicable because the study evaluated the effect of blind versus open trials on retention (Avenell [@b2]).

### Incomplete outcome data

The primary outcome measure for this review was retention, and this was well reported. We contacted authors for clarification of any exclusions after randomisation if this was unclear from retention trial reports.

### Selective reporting

Although retention trial protocols were not available for included trials, the included published and unpublished papers reported all expected outcomes for retention.

### Other potential sources of bias

There were few other potential sources of bias identified from reports of included retention trials. For the behavioural trial by Cox [@b15], the authors identified that the \"walk and swim sessions were not separated according to the behavioural intervention. Participants were asked not to discuss written materials in the practical sessions\". Therefore, potential contamination between study groups could have led to biased results.

Effect of methods
-----------------

### 1. Incentive strategies

There were 14 trials of incentives giving 19 trial comparisons with 16,253 participants. There was considerable heterogeneity across incentive subgroups (P value \< 0.00001) (Analysis 1.1), so we decided not to pool the results for incentives.

#### Addition of incentive

The three trials (3166 participants) that evaluated the effect of giving monetary incentives to participants showed that the addition of monetary incentives was more effective than no incentive at increasing response to postal questionnaires (RR 1.18; 95% CI 1.09 to 1.28, P value \< 0.0001) (Analysis 1.1). A sensitivity analysis excluding the quasi-randomised trial by Gates [@b19] still showed that the addition of a monetary incentive remained more effective than none (RR 1.31; 95% CI 1.11 to 1.55, P value = 0.002) (Analysis 2.1).

Based on two Internet-based trials (3613 participants), an offer of a monetary incentive promoted greater return of electronic questionnaires than no offer (RR 1.25; 95% CI 1.14 to 1.38, P value \< 0.00001; heterogeneity P value = 0.14) (Analysis 1.1). However, a single trial comparison suggested that an offer of a monetary donation to charity did not increase response to electronic questionnaires (RR 1.02; 95% CI 0.78 to 1.32; P value = 0.90) (Analysis 1.1).

Based on six trials (6322 participants), there was no clear evidence that the addition of non-monetary incentives improved questionnaire response (RR 1.00; 95% CI 0.98 to 1.02, P value = 0.91), but there was some heterogeneity (P value = 0.02) (Analysis 1.1). A sensitivity analysis excluding the quasi-randomised trial (Bowen [@b9]) showed a similar effect (RR 1.00; 95% CI 0.93 to 1.08, P value = 0.99) (Analysis 2.1) and heterogeneity (P value = 0.01).

Two trials (1138 participants) evaluating offers of non-monetary incentives suggest that an offer of a non-monetary incentive is neither more nor less effective than no offer (RR 0.99; 95% CI 0.95 to 1.03, P value = 0.60) at improving questionnaire response (Analysis 1.1).

In exploratory analyses, the different incentive arms that were combined for the main analysis did not appear to show differential effects (Analysis 3.1).

#### Addition of monetary incentive to both study arms

Two trials (902 participants) show that higher value incentives are better at increasing response to postal questionnaires than lower value incentives (RR 1.12; 95% CI 1.04 to 1.22, P value = 0.005) irrespective of how they are given (Analysis 5.1).

#### Addition of monetary incentive versus offer of a monetary incentive

Two trials (297 participants) provided no evidence that giving a monetary incentive is better than an offer of entry into a prize draw for improving response to postal questionnaires (RR 1.04; 95% CI 0.91 to 1.19, P value = 0.56) Analysis 6.1.

#### Addition of an offer of entry into a prize draw versus none

We excluded one trial from the analysis (Leigh [@b35]). The results showed higher responses in the group offered entry into a prize draw compared with the group not offered entry into the draw (70.5% versus 65.8%).

### 2. Communication strategies

There were 14 trials of communication strategies and 20 comparisons with 9822 participants.

#### Addition of telephone survey versus monetary incentive plus questionnaire

One trial (700 participants) showed no clear evidence that a telephone survey was either more or less effective than a monetary incentive and a questionnaire for improving response (RR 1.08; 95% CI 0.94 to 1.24, P value = 0.27) (Analysis 4.1).

#### Enhanced versus standard letters

Results from two trials (2479 participants) showed that an enhanced letter was neither more nor less effective than a standard letter for increasing response to trial postal questionnaires (RR 1.01; 95% CI 0.97 to 1.05, P value = 0.70) (Analysis 7.1).

#### Total design method versus customary method

Although based on a single trial (226 participants) the TDM package was more effective than a customary postal communication method at increasing questionnaire return (RR 1.43; 95% CI 1.22 to 1.67, P value \< 0.0001) (Analysis 8.1).

#### Priority versus regular post

Based on the relevant arms of seven trials (1888 participants), there was no clear evidence that priority post was either more or less effective than regular post at increasing trial questionnaire return (RR 1.02; 95% CI 0.95 to 1.09, P value = 0.55) (Analysis 9.1).

#### Additional reminder versus usual follow-up practices

Six trials (3401 participants) evaluated the effect of different additional types of reminders to participants on questionnaire response. There was no evidence that a reminder was either more or less effective than no reminder at improving trial questionnaire response (RR 1.03; 95% CI 0.99 to 1.06, P value = 0.13) (Analysis 10.1).

#### Additional reminder to trial site versus usual reminder

Based on one cluster randomised trial (272 participants), a monthly reminder to trial sites of upcoming assessment was neither more nor less effective than the usual follow-up (RR 0.96; 95% CI 0.83 to 1.11, P value = 0.57) (Analysis 11.1).

#### Early versus late questionnaire administration

Based on one trial (664 participants), there was no clear evidence that sending questionnaires early either increased or decreased response (RR 1.10; 95% CI 0.96 to 1.26, P value = 0.19 (Analysis 12.1).

#### Recorded delivery versus telephone reminder

One small trial (192 participants) found that recorded delivery was more effective than a telephone reminder (RR 2.08; 95% CI 1.11 to 3.87; P value = 0.02) (Analysis 13.1).

### 3. New questionnaire strategies

#### New versus standard questionnaire

Eight trials with 10 comparisons (21,505 participants) evaluated the effect of a new questionnaire format on questionnaire response. Although there was some heterogeneity between the questionnaire subgroups (P value = 0.11) (Analysis 14.1), it did not seem reasonable to pool the results based on such different interventions.

Five trials (7277 participants) compared the effect of short questionnaires versus long on postal questionnaire response. There was only a suggestion that short questionnaires may be better (RR 1.04; 95% CI 1.00 to 1.08, P value = 0.07) (Analysis 14.1).

Based on one trial (900 participants; Subar [@b68]), there is no evidence that long and clear questionnaires were either more or less effective than shorter condensed questionnaires for increasing trial questionnaire response (RR 1.01; 95% CI 0.95 to 1.07, P value = 0.86) (Analysis 14.1).

Two trials (9435 participants; McColl [@b48]; McColl [@b49]) found no evidence that placing disease/condition questions before generic questions is either a more or less effective strategy than a generic questions before disease/condition questions strategy at increasing trial questionnaire response (RR 1.00; 95% CI 0.97 to 1.02, P value = 0.75) (Analysis 14.1). It should be noted that these were quasi-randomised trials (Analysis 15.1).

One trial in this category was not included in the analysis by Letley [@b36], outcome data were not available for each study arm when this review was submitted and the overall response rate for this trial was 87%.

In the context of research on reducing alcohol consumption, there was also evidence that more relevant questionnaires (i.e. those relating to alcohol use) increased response rates (RR 1.07; 95% CI 1.01 to 1.14, P value = 0.03).

### 4. Behavioural/motivational strategies

Two community-based trials (273 participants; Chaffin [@b12]; Cox [@b15]) showed no evidence that the behavioural/motivational strategies used are either more or less effective than standard information for retaining trial participants (RR 1.08; 95% CI 0.93 to 1.24, P value = 0.31) (Analysis 16.1).

### 5. Case management

One trial (703 participants; Ford [@b18]) evaluated the effect of intensive case management procedures on retention. There is no evidence that intensive case management was either more or less effective than usual follow-up in the population examined (RR 1.00; 95% CI 0.97 to 1.04, P value = 0.99) (Analysis 17.1).

### 6. Methodology strategies

One fracture prevention trial (538 participants; Avenell [@b2]) evaluated the effect of participants knowing their treatment allocation (open trial) compared with participants blind/unaware of their allocation on questionnaire response. Using a trial design where people know which treatment they will receive led to higher questionnaire response rates (RR 1.37; 95% CI 1.16 to 1.63, P value = 0.0003) (Analysis 18.1).

### Reporting bias

Although we planned to investigate potential reporting bias, there were too few studies in most strategies to allow formal testing. However, we were able to obtain considerable data from unpublished trials and those published with limited information, reducing the risk of such biases.

### Absolute benefits of strategies to improve retention

The absolute benefits of effective strategies on questionnaire response are illustrated in [Table 4](#tbl4){ref-type="table"}. The baseline response rates were broadly typical of the response rates seen in trials. The number of questionnaires returned were based on the assumed control arm risk.

###### 

Gain in number of questionnaires returned per 1000 questionnaires sent

  Example of proportion of questionnaires returned in control arm                                                  30%   40%   50%   60%   70%   80%   90%
  ----------------------------------------------------------------------------- -------- ------------------------- ----- ----- ----- ----- ----- ----- -----
  **Strategy to improve retention**                                             **RR**   **[^1^]{.ul}** **~RR~**                                       
                                                                                                                                                       
  Addition of monetary incentive versus none                                    1.18     0.847                     107   92    76    61    5     3     2
                                                                                                                                                       
  Addition of offer of monetary incentive/prize draw versus none                1.25     0.800                     140   120   100   80    60    40    20
                                                                                                                                                       
  Addition of higher value monetary incentive versus addition of lower amount   1.12     0.890                     77    66    55    44    33    22    11

RR: risk ratio.

Based on a 40% baseline response rate for postal questionnaires, the addition of a monetary incentive was estimated to increase response by 92 questionnaires per 1000 sent (95% CI 50 to 131).

With the addition of an offer of a monetary incentive in an Internet-based trial, based on a baseline response rate of 30%, trialists could expect an increase of 140 questionnaires per 1000 (95% CI 86 to 193).

For trials hoping to increase the return of postal questionnaires with chlamydia test kits, the number of kits returned was estimated to increase by 33 per 1000 sent when GBP20 was offered as an incentive, rather than GBP10 (95% CI 11 to 54).

Discussion
==========

Summary of main results
-----------------------

Thirty-eight randomised retention trials were included in this review, evaluating six broad types of strategies to increase questionnaire response and retention in randomised trials. In 34 trials, strategies for increasing response to questionnaires were: incentives, communication strategies, new questionnaire format and methodological interventions. Four trials evaluated strategies to improve retention, these were: participant case management, behavioural and non-monetary incentive strategies. Trials were conducted across a spectrum of disease areas, countries, healthcare and community settings.

Strategies with the clearest impact on questionnaire response were: addition of monetary incentives compared with no incentive for return of postal questionnaires, addition of an offer of a monetary incentive when compared with none for return of electronic questionnaires, and an offer of GBP20 vouchers when compared with GBP10 for return of postal questionnaires and biomedical test kits. The evidence was less clear about whether shorter questionnaires rather than longer questionnaires increased response. The evidence was also less clear whether in the context of research on reducing alcohol consumption more relevant questionnaires increased response.

The addition of a non-monetary incentive, an offer of a non-monetary incentive compared with no incentive or, \'enhanced\' letters, letters delivered by priority post, or additional reminders compared with standard communication strategies did not increase or decrease trial questionnaire response. Questionnaire structure also did not seem to increase response.

Although each was based on the results of a single trial, recorded delivery (proof of posting and an electronic copy of the signature available online) of questionnaires seemed more effective than telephone reminders, and a \'package\' of postal communication strategies with reminder letters appeared better than standard procedures. A trial design where participants knew which treatment they were to receive also appeared more effective than a trial design where they were unaware of the treatment they were about to receive for return of questionnaires in a fracture prevention trial. Further evaluation of these strategies may be needed. Posting questionnaires early, questionnaire order, offers of charity donations or sending reminders to trial sites did not improve response.

Many trial outcome measures were collected using questionnaires, therefore, if response rates can be increased, retention will also be improved. No strategy had a clear impact on increasing the number of participants returning to trial sites for follow-up visits.

Overall completeness and applicability of evidence
--------------------------------------------------

The addition of a GBP5 voucher to usual follow-up procedures was effective for return of postal questionnaires in trials conducted between 2005 and 2009. The more recent unpublished studies by Bailey [@b3] Bailey [@b4] found GBP20 vouchers were more effective than GBP10 vouchers for return of postal questionnaires. Splitting the monetary incentive into money given before and after receipt of data could be more effective as a strategy to increase questionnaire follow-up with different population groups and in different trial settings where questionnaire response is low (e.g. with hard to reach groups that may include young male healthy adults, teenagers or residents in areas of high economic deprivation). This could be a cost-effective strategy because if questionnaires are not returned then money is saved. The value of the monetary incentive should not be so high as to be perceived as payment for data but more as an appreciation for efforts made by participants. Offering monetary incentives may increase the number of questionnaires returned per 1000 participants by at least as much as giving monetary incentives and giving higher valued monetary incentives, but has only been tested in online questionnaires. Offers of monetary incentives were also an effective strategy in the context of an online electronic questionnaire. These could be less costly to increase retention than the addition of a monetary incentive as only those who return the data are reimbursed. This would need further evaluation as the results were based on two Internet-based trials. It would be beneficial for trialists to know which is more effective: an offer of a monetary incentive or an upfront monetary incentive. We did not find any trials that made this direct comparison.

Shorter postal questionnaires have wide applicability to trials and could be considered as a useful strategy to increase trial questionnaire response in online Internet-based trials but there is only a suggestion that these are effective.

Several strategies showed no clear effect. The addition of non-monetary incentives in the form of pens, lapel pins and certificates of appreciation, or offers of non-monetary incentives through offering study results did not increase response or retention. A possible explanation might be how these items are valued by participants, or how they perceive their time is valued. Nevertheless, this result has the potential to reduce trial costs because associated saving could be channelled towards monetary incentives that have been shown to be effective.

The evidence showed that priority post (first-class post or equivalent) did not increase response. It is expensive as a means of communicating with participants and savings can be made by using regular (2nd-class) post instead.

Additional reminders sent to non-responders or as questionnaires were posted; enhanced letters, that is, letters signed by the principal investigator, or letters further explaining the anticipated length of time to complete a questionnaire, were not effective strategies to increase response. Enhanced letters and different types of additional reminders are used by trialists in current research practice. Too many reminders could be counterproductive to improving retention in randomised trials and details of the time expected to undertake specific tasks might be informative but off putting for participants. Nevertheless, letters and reminders are part of the research process and play a role in participant engagement especially if there is little face-to-face contact or in trials with long intervals between data collection time points.

Several strategies to increase questionnaire response need further evaluation to determine their effect but there is only a suggestion that these were effective. If participants are well and engaged with a trial, questionnaire length may not impact on response rates because participants may be happy to feedback on their condition in this way. For other conditions, for example, cancers and terminal illnesses, trial participants might prefer shorter questionnaires if their symptoms are problematic. Telephone follow-up compared with monetary incentive sent with a questionnaire needs further evaluation possibly with a cost-benefit analysis, as both could be expensive in time and human resources. Although appearing very effective, the total design method for postal questionnaires could be labour intensive to implement, expensive and may no longer be applicable to some participant groups (e.g. young people), or in trials using email, text or the Internet to collect data. Recorded delivery could be useful to ensure trial follow-up supplies reach their intended destination (e.g. biomedical specimen kits and questionnaires). Careful planning of day, date and time of delivery with each participant to avoid inconvenience might be necessary but again this strategy has the potential to be burdensome for trial co-ordinating centres and trial sites to administer. While trialists are assured that follow-up supplies are delivered with this strategy, participants might have the added burden of an extra visit to collect supplies from a sorting post office and this could be costly.

The use of open trials to increase questionnaire response can only be applied to trials where blinding is not required and could be counterproductive if a participant or clinician has a treatment preference. Bias associated with loss to follow-up resulting from these preferences could be avoided in blind trials.

Evaluations of strategies that encourage participants to return to trial sites for follow-up visits and monitoring were fewer than strategies to increase response to postal and electronic questionnaires, without further evidence case management and behavioural strategies cannot be recommended for use to encourage participant return.

This review identified no trials from low-income countries. All included studies were conducted in higher-income countries. Therefore, the strategies to increase retention identified by this review may not be generalisable to trials conducted in low-income countries because the interventions identified might not be socially, culturally or economically appropriate for trials run in these regions. The results may also not be applicable to all social groups as we were unable to examine response/retention by social characteristics such as economic disadvantage and social class. Most of the evidence in this review relates to increasing questionnaire follow-up in randomised trials for either the primary or secondary outcome for the host trial. The diversity between strategies and insufficient numbers in each of these categories meant that we could not do subgroup analyses by trial setting and disease area as planned.

Quality of the evidence
-----------------------

The extent of unpublished trials evaluating retention strategies is unknown; however, this review includes several unpublished trials and we made an effort to capture UK-based unpublished trials through our survey and research contacts. For some comparisons, results were based on one or two trials in a particular context. The inclusion of any further published and unpublished trials in future updates would improve the precision of the results of this review.

The six types of strategies that we identified targeted retention of trial participants in randomised trials. We believe response and retention were the relevant dichotomous outcomes to be reported for this review. Many other strategies used by trialists in practice to reduce attrition/increase response or retention in trials were not identified by this review (e.g. social support strategies; child care, Loue [@b140]; family support, De [@b113]; reduction in the number of visits, Schulz [@b154]). Evaluations of trial management strategies are also under-represented in the review (e.g. evaluations of site-specific reports, El [@b120]; levels of contact by the co-ordinating centre, Senturia [@b156]; training project staff).

Both published and unpublished included retention trials were fairly well conducted but could be improved. Five of the 39 trials included in the review were quasi-randomised. The motivation for conducting many of the included retention trials was reactive rather than planned upfront (i.e. when loss to follow-up became a problem during trial follow-up, rather than planned prior to host trial commencement).

Most trials used appropriate methods for randomisation or at least stated that they were randomised. For trials that did not describe their methods well or provide further information, there remains a potential risk of selection bias. Sensitivity analyses excluding quasi-randomised trials did not affect the results. In this context, where motivating participants to provide data or attend clinics is often the target of the interventions and so appropriately influences the outcome, lack of blinding is less of a concern. Retention is the outcome and was obtained for all but two trials, so similarly, attrition and selective outcome reporting bias are unimportant. Although the retention trials were fairly well conducted, they could be improved and they were often poorly reported. This may be because they were designed when loss to follow-up became a problem in a trial, rather than preplanned prior to host trial commencement.

Potential biases in the review process
--------------------------------------

Many words are used to describe loss to follow-up, for example, attrition, withdrawal and questionnaire non-response. We included these in our search strategy. We attempted to obtain unpublished trials and data by contacting authors and writing to UK clinical trials units and presenting at national and international conferences. We are confident that we have captured most studies and the spectrum of strategies that have been evaluated to date. It is conceivable, however, that less well-reported, ongoing, unpublished trials or trials conducted outside of the UK might have been missed. Most trials used appropriate methods for sequence generation or at least stated that they were randomised and concealed allocation. There is small risk that those that did not describe their methods well or provide further information did not use adequate methods for allocation and concealment and may have biased the results. However, sensitivity analyses excluding quasi-randomised trials did not affect the results. Blinding is hard to achieve in this context, where motivating participants to provide data or attend clinics is often the target of the interventions and so appropriately influences the outcome.

Agreements and disagreements with other studies or reviews
----------------------------------------------------------

The strategies that improve retention are, in some cases, the same as or similar to those found to be effective for cohort and cross-sectional study designs. However, prior to our review, it was not clear which of these strategies could be extrapolated to randomised trials. Successful retention strategies used in other study designs may be effective in trials settings and should be tested. Edwards\' review on methods to increase response to postal and electronic questionnaires included 513 trials and identified many strategies to increase response to questionnaires (Edwards [@b118]). Included trials were embedded in surveys, cohort studies and trials, which may explain some of the heterogeneity in effects seen in Edwards\' review and reliance on the random-effects model. Unexplained heterogeneity was not a particular problem in this review. Edwards found monetary incentives effective for increasing response to postal questionnaires (Edwards [@b118]). However, unlike our review, Edwards found that non-monetary incentives were effective for postal and electronic questionnaires. Other strategies found to be effective by Edwards, in agreement with our review, included recorded delivery of questionnaires and shorter questionnaires, although in our review shorter questionnaires need further evaluation. Edwards also found that use of hand-written addresses, stamped return envelopes as opposed to franked return envelopes and first-class outward mailing improved response. Our review found that a \'package\' including an enhanced letter incorporating several reminders was effective, but the effectiveness of first-class/priority mail to increase response in randomised trials was unclear.

Booker\'s narrative review of methods to increase retention in population-based cohort studies was based on only 11 randomised trials and no meta-analysis (Booker [@b107]). The results suggested that incentives were associated with an increase in retention.

Nakash\'s systematic review of ways to increase response to postal questionnaires in health care focused on randomised trials of ways to increase response to postal questionnaires in healthcare research on participant populations (Nakash [@b144]. Fifteen trials were included in this meta-analysis, which found that reminder letters, telephone contact and short questionnaires increased response to postal questionnaires in the context of healthcare research. There was no evidence that incentives were effective. Again, this review was not exclusive to evaluations conducted in randomised trials.

The Edwards review was broad and focused specifically on methods to enhance response to questionnaires and included studies in non-healthcare settings (Edwards [@b118]). The reviews by Nakash and Booker focused on retention in specific research areas, health care and cohort studies (Booker [@b107]; Nakash [@b144]). Unlike these reviews, our review focused specifically on a range of strategies evaluated within trials. Therefore, it specifically addressed the question of retention of study participants within randomised trials, which was beyond the scope of the other reviews. Application of these results would depend on trial setting, population, disease area, data collection and follow-up procedures. Moreover, we identified additional strategies that may improve trial retention, for example, methodological strategies.

This review is the most comprehensive to date on strategies specifically designed to improve retention in randomised trials. We included seven unpublished trials and 18 other trials not included by Edwards (Edwards [@b118]).

Authors\' conclusions
=====================

Implication for methodological research
---------------------------------------

Trialists may consider including well thought out and adequately powered evaluations of strategies to increase retention in randomised trials. This could include a clear definition of retention strategies and of measures of retention. Trialists conducting future methodology trials can consider incorporating evaluations of strategies to increase retention at the design stage so that power, sample size and funding arrangements are taken into account. Retention trials were often poorly reported without consort diagrams, clear primary outcomes, sample size, sociodemographic composition or power calculations. Considerable time was spent contacting authors for unreported data needed for a robust meta-analysis. Trialists in their reports might consider adhering to the consort guidelines for trial reporting, which would facilitate the synthesis of results in future methodology reviews. There is less research on ways to increase return of participants to trial sites for follow-up and on the effectiveness of strategies to retain trial sites in cluster and individual randomised trials. Research in both areas would be very beneficial to trialists. There is no current system for identifying methodological trials in progress, until a system is set up it may be useful for systematic review authors to incorporate contacting trials units into their search strategy.
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Appendix 1. Attrition terms
===========================

Cochrane Central Register of Controlled Trials (CENTRAL) and Database of Abstracts of Reviews of Effects (DARE in *The Cochrane Library*) were searched using attrition terms shown below.

(minimi\$ adj2 attrition).ab,ti.

(prevent\$ adj2 attrition).ab,ti.

(lessen\$ adj2 attrition).ab,ti.

(decreas\$ adj2 attrition).ab,ti.

(reduc\$ adj2 attrition).ab,ti.

(minimi\$ adj2 drop-out).ab,ti.

(prevent\$ adj2 drop-out).ab,ti.

(lessen\$ adj2 drop-out).ab,ti.

(decreas\$ adj2 drop-out).ab,ti.

(reduc\$ adj2 drop-out).ab,ti.

(minimi\$ adj2 drop-out\$).ab,ti.

(prevent\$ adj2 drop-out\$).ab,ti.

(lessen\$ adj2 drop-out\$).ab,ti.

(decreas\$ adj2 drop-out\$).ab,ti.

(reduc\$ adj2 drop-out\$).ab,ti.

(minimi\$ adj2 drop\$-out).ab,ti.

(prevent\$ adj2 drop\$-out).ab,ti.

(lessen\$ adj2 drop\$-out).ab,ti.

(decreas\$ adj2 drop\$-out).ab,ti.

(reduc\$ adj2 drop\$-out).ab,ti.

minimi\$ adj2 dropout\$).ab,ti.

(prevent\$ adj2 dropout\$).ab,ti.

(lessen\$ adj2 dropout\$).ab,ti.

(decreas\$ adj2 dropout\$).ab,ti.

(reduc\$ adj2 dropout\$).ab,ti

(strateg\$ adj2 drop\$-out) .ab,ti.

(strateg\$ adj2 dropout\$).ab,ti.

(loss adj2 follow-up).ab,ti.

(lost adj2 follow-up).ab,ti.

(loss adj2 followup).ab,ti.

(lost adj2 followup).ab,ti.

(minimi\$ adj2 withdrawal).ab,ti.

(prevent\$ adj2 withdrawal).ab,ti.

(lessen\$ adj2 withdrawal).ab,ti.

(decreas\$ adj2 withdrawal).ab,ti.

(reduc\$ adj2 withdrawal).ab,ti.

(minimi\$ adj2 withdrawal\$).ab,ti.

(prevent\$ adj2 withdrawal\$).ab,ti.

(lessen\$ adj2 withdrawal\$).ab,ti.

(decreas\$ adj2 withdrawal\$).ab,ti.

(reduc\$ adj2 withdrawal\$).ab,ti.

(strateg\$ adj2 attrition).ab,ti.

(strateg\$ adj2 drop-out).ab,ti.

(strateg\$ adj2 dropout).ab,ti.

(strateg\$ adj2 follow-up).ab,ti.

(strateg\$ adj2 followup).ab,ti.

(increas\$ adj2 retention).ab,ti.

(encourag\$ adj2 retention).ab,ti.

(maximi\$ adj2 retention).ab,ti.

(promot\$ adj2 retention).ab,ti.

(improv\$ adj2 retention).ab,ti.

(strateg\$ adj2 response\$).ab,ti.

(strateg\$ adj2 (questionnaire\$ adj3 response\$)).ab,ti.

(increas\$ adj2 (questionnaire\$ adj3 response\$)).ab,ti.

(encourag\$ adj2 (questionnaire\$ adj3 response\$)).ab,ti.

(maximi\$ adj2 (questionnaire\$ adj3 response\$)).ab,ti.

(promot\$ adj2 (questionnaire\$ adj3 response\$)).ab,ti.

(improv\$ adj2 (questionnaire\$ adj3 response\$)).ab,ti.

(increas\$ adj2 response\$).ab,ti.

(encourag\$ adj2 response\$).ab,ti.

(maximi\$ adj2 response\$).ab,ti.

(promot\$ adj2 response\$).ab,ti.

(improv\$ adj2 response\$).ab,ti.

(retention adj2 strateg\$).ab,ti.

retention rate\$.ab,ti.

(retention adj2 method\$).ab,ti.

(retention adj2 technique\$).ab,ti.

attrition rate\$.ab,ti.

(questionnaire\$ adj3 (response\$ adj2 method\$)).ab,ti.

(questionnaire\$ adj3 (response adj2 technique\$)).ab,ti.

(questionnaire adj response rate\$).ab,ti. (1145)

(difficult\$ adj2 (retain\$ or retention)).ab,ti.

Participant Dropouts/

The search syntax was adapted as follows for different search interfaces

**MEDLINE; EMBASE; PsycINFO via Ovid,**

**pt**- Publication type.

**adj2-** words within 2 words of each other.

**ab**- word in abstract.

**sh**- sub heading.

**ti** word in title.

**/** - Subject heading Medline.

**\$** - Truncation symbol.

Codes used to de duplicate in Ovid were:

use mesz

use emez

use psyh

**Cochrane Central Register of Controlled Trials (CENTRAL) and Database of Abstracts of Reviews of Effects (DARE) via *The Cochrane Library***

**\*** Truncation symbol

NEAR/2 - words within 2 words of each other.

:kw- keyword

Codes used to de duplicate in CENTRAL were:

\"accession number \" near pubmed

\"accession number \" near2 embase

**CINAHL (Cumulative Index to Nursing and Allied Health; 1981 to present) via EBSCOHost**

**MH** Major heading (CINAHL via EBSCOHost -)

**+**- (e.g.Treatment Outcomes**+)** (CINAHL via EBSCOHost -)

**N2** - words within 2 words of each other.

**\*** Truncation symbol.

**Campbell Collaboration\'s Social, Psychological, Educational and Criminological Trials** Register (C2-SPECTR **<http://geb9101.gse.upenn.edu/>**

**\*** - Truncation symbol.

**Education Resource Information Centre (ERIC) via Dialog datastar.**

**\$** - Truncation symbol

**ab**- word in abstract.

**ti** word in title.

**MeSH Headings**

**exp Pa**rticipa**nt Dropouts**/: This was used in MEDLINE, only as a subject heading.

In PsycINFO**Experimental attrition** was used

In CINAHL plus**Research subject retention** was used ("research dropouts"- term scope = mechanisms used to keep study participants willing and able to contribute to participate in the study for its duration).

Search strategy for **MEDLINE** Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: Sensitivity and precision maximising version, 2008 revision Lefebvre [@b137]; Ovid format.

\#1 randomized controlled trial.pt.

\#2 controlled clinical trial.pt.

\#3 randomized.ab.

\#4 placebo.ab.

\#5 clinical trials as topic.sh.

\#6 randomly.ab.

\#7 trial.ti.

\#8 1 or 2 or 3 or 4 or 5 or 6 or 7

\#9 exp animals/ not humans. sh.

\#10 8 not 9

\#11 10 AND Attrition terms ([Appendix 1](#app1){ref-type="app"})

**EMBASE** search using a sensitivity and specificity maximising search strategy for identifying clinically sound treatment studies Wong [@b167].

\#1 random\$.tw.

\#2 placebo\$.ti,ab,sh.

\#3 double-blind\$.tw.

\#4 1 or 2 or 3

\#5 4 AND Attrition terms ([Appendix 1](#app1){ref-type="app"})

**PsycINFO** search strategy for identifying high quality studies on treatment: Sensitivity and specificity maximising version. Eady [@b115]

\#1 double-blind.ab,ti.

\#2 \"random\$ assigned.\".ab,ti.

\#3 control.ab,ti.

\#4 1 or 2 or 3

\#5 4 AND Attrition terms ([Appendix 1](#app1){ref-type="app"})

**CINAHL** search strategy for identifying therapy studies and review articles: Sensitivity and specificity maximising version Wong [@b168]

\#1 PT Clinical trial

\#2 (MH \"Treatment Outcomes+\")

\#3 randomi?ed

\#4 1 or 2 or 3

\#5 4 AND Attrition terms ([Appendix 1](#app1){ref-type="app"})

Campbell Collaboration\'s Social, Psychological, Educational and Criminological Trials Register C2-SPECTR advanced search Non-indexed fields and indexed fields.

Terms used: {retention} OR {attrition} OR {dropout} OR {drop-out} OR {withdrawal} OR {response}.

**ERIC** search strategy Petrosino [@b146]

\#1 RANDOMI\$.TI,AB.

\#2 RANDOM\$.TI,AB.

\#3 (ALLOCAT\$ OR ALLOT\$ OR ASSIGN\$ OR BASIS OR DIVID\$ OR ORDER\$).TI,AB.

\#4 (2 NEAR 3).TI,AB.

\#5 RANDOM\$.TI,AB. NOT (4 ADJ or1).TI,AB.

\#6 ((SINGL\$ OR DOUBL\$ OR TREBL\$ OR TRIPL\$) NEAR (BLIND\$ OR MASK\$)).TI,AB.

\#7 ((COMPAR\$ OR CONTROL\$ OR EXPERIMENT\$ OR INTERVENT\$ OR THERAP\$ OR TREATMENT\$) NEAR (GROUP\$ OR CLASS\$)).TI,AB.

\#8 (ALLOCAT\$ OR ALLOT\$ OR ASSIGN\$ OR DIVID\$ OR ORDER\$).TI,AB.

\#9 (7 NEAR 8).TI,AB.

\#10 crossover.TI,AB.

\#11 (LATIN NEAR SQUARE).TI,AB.

\#12 ((CLINIC\$ OR CONTROL\$) NEAR (TRIAL\$ OR STUDY\$ OR STUDIES\$)).TI,AB.

\#13 PLACEBO\$

\#14 (1 OR 4 OR 5 OR 6 OR 9 OR 10 OR 11 OR 12 OR 13).TI,AB.

\#15 Attrition

\#16 (attrition ADJ research ADJ studies). TI,AB.

\#17 14 AND 16

\#18 17 AND Attrition terms ([Appendix 1](#app1){ref-type="app"})
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Clinical area main trialConditionParticipantsSettingAttrition StudyTreatment of dependenceAlcoholAdults scoring +5 on AUDIT-C, mean age 37 years in an online trial comparing interactive computer intervention plus website information vs. website information for modifying alcohol intake Murray [@b143]Community: onlineKhadjesari [@b29]AlcoholAdults scoring +5 on AUDIT-C mean age 37 years in an online trial comparing interactive computer intervention plus website information vs. website information for modifying alcohol intake Murray [@b143]Community: onlineKhadjesari [@b33]AlcoholAdults scoring +5 on AUDIT-C mean age 37 years in an online trial comparing interactive computer intervention plus website information vs. website information for modifying alcohol intake Murray [@b143]Community: onlineMcCambridge [@b41]AlcoholAdults scoring +5 on AUDIT-C mean age 37 years in an online trial comparing interactive computer intervention plus website information vs. website information for modifying alcohol intake Murray [@b143]Community: onlineMcCambridge [@b44]SmokingAdult smokers aged 38-77 years in a smoking cessation trial of public education through media and community wide events, healthcare providers work sites and other organisations vs. no intervention Gail [@b125]USA communityBauer [@b6]SmokingAdult smokers mean age 36.7 years in a trial of nicotine gum vs. placebo gum. Smokers for = 1 year Hughes [@b132]USA communityHughes [@b20]SmokingAdult smokers willing to quit aged = 16 years in a trial comparing Txt2stop motivational messages and behaviour change support vs. text messages unrelated to quitting Free [@b123]UK communitySeveri [@b57]SmokingAdult smokers willing to quit aged = 16 years in a trial comparing Txt2stop motivational messages and behaviour change support vs. text messages unrelated to quitting Free [@b123]UK communitySeveri [@b58]Treatment of injuryNeckMINT trial: adults with whiplash injury 18-87 years in a 2 x 2 cluster randomised trial comparing whiplash book vs. usual advice. Individuals randomised to physiotherapy vs. single advice session reinforcing advice given Lamb [@b135]UK hospital trustsGates [@b19]AnkleCast trial: adults aged 16-57 years with acute severe ankle sprain in a trial comparing tubular bandage vs. below knee cast vs. Aircast® ankle brace vs. Bledsoe® boot Cooke [@b110]UK accident and emergency departmentsNakash [@b50]\*HeadAdults with head injury aged = 16 years in trial of 48-hour infusion of methylprednisolone vs. placebo CRASH [@b111]UK hospital intensive care unitsEdwards [@b17]\*HeadAdults with head injury = 16 years CRASH trial: 48-hour infusion of methylprednisolone vs. placebo CRASH [@b111]Czech republic hospital intensive care unitsSvoboda [@b70]\*Treatment of diseaseBreast cancerWomen with ductal carcinoma in situ aged = 49 years in a trial comparing anastrozole vs. tamoxifen (unpublished)USA, Canada, Puerto Rico hospitalsLand [@b34]StrokeAcute stroke patients 50-80 years in an international stroke trial of heparin 125,000 IU twice daily + aspirin 300 mg daily vs. heparin 125,000 IU twice vs. heparin 5000 IU twice daily + aspirin 300 mg daily, heparin 5000 IU twice daily vs. aspirin 300 mg daily vs. no heparin or aspirin International [@b133]UK hospitalDorman [@b16]Ventricular fibrillation, ventricular tachycardiaAdults cardioverted from ventricular tachycardia or resuscitated from ventricular fibrillation aged 54-76 years participating in the AVID trial comparing an implanted cardioverter defibrillator vs. antiarrhythmic drugs AVID [@b106]USA hospitalRenfroe [@b52]EpilepsyAdults with epilepsy mean 38.3 years in the SANAD trial. Arm a: carbamazepine vs. gabapentin vs. lamotrigine vs. oxcarbazepine vs. topiramate. Arm b: valproate vs. lamotrigine (LTG) vs. vs topiramate (TPM) Marson [@b141]UK hospital outpatient departmentsMarson [@b39]†Back painAdults with low back pain aged 18-65 years in a trial comparing exercise manipulation vs. exercise plus manipulation UK [@b164]UK primary careLetley [@b36]‡Back painAdults aged 18-65 years in a trial comparing yoga vs. usual care Tilbrook [@b160]UK primary careMan [@b38]ScreeningProstate, lung, ovarian, colorectal cancerAdults aged 55-74 years in PLCO trial comparing PSA and CA125 at baseline, and annually for 5 years. Digital rectal examination, transvaginal ultrasound and chest x-ray at baseline and 5 years vs. usual follow-up Prorok [@b148]USA trial sitesSubar [@b68], Ford [@b18] (African American men aged ≥ 55 years only from PLCO)CervicalWomen with low-grade abnormal cervical smear aged 20-59 years in the TOMBOLA trial: Colposcopy vs. 6-monthly smears TOMBOLA [@b161] TOMBOLA [@b162]UKSharp [@b60]Postnatal depressionWomen childbearing aged = 18 years \< 2 weeks\' postpartum at high risk of postnatal depression in a trial comparing proactive individualised telephone-based peer support vs. standard postpartum care Dennis [@b114]Canada communityKenton [@b22]PreventionFractureAdults with history of osteoporotic fracture = 70 years in the RECORD trial: oral calcium + vitamin D vs. oral calcium vs. vitamin D vs. placebo RECORD [@b149]UK hospital[@b37]\*FractureAdults with history of osteoporotic fracture aged = 70 years in the RECORD trial: oral calcium + vitamin D vs. oral calcium vs. vitamin D vs. placebo RECORD [@b149]UK hospitalAvenell [@b2]FractureWomen with hip fracture risk factors aged = 70 years in a fracture prevention trial of calcium 1000 mg plus vitamin D~3~ 800 IU plus information sheet on dietary calcium intake and falls prevention vs. information sheet Porterhouse [@b147]UK primary careCockayne [@b13]MigraineAdults history of 2 migraine attacks aged 18-65 years with migraine randomised to true diet vs. sham diet (unpublished)UK communityAshby [@b1]Lung cancerAdults exposed to smoking and asbestos aged = 45 years in the CARET trial 2 x 2: beta-carotene + retinol daily vs. beta-carotene vs. retinol vs. placebo Omenn [@b145]USA trial sitesBowen [@b9]Breast cancerWomen with 50% of breast volume dysplasia = 30 years in Canadian diet and cancer prevention trial. Counselling and individualised dietary prescription vs. taught principals of a healthy diet not counselled to change fat content Boyd [@b108]Canada Hospital clinicSutherland [@b69]Clinical managementAsthmaAdult with asthma = 70 years in COGENT trial: computerised decision support guidelines for asthma vs. angina care Eccles [@b117]UK primary careMcColl [@b47]Asthma and diabetesAdults with asthma mean age 47 years. Study template for diabetes vs. study template for asthma Tai [@b159]UK primary careTai [@b71]AnginaAdult with asthma aged = 70 years in the COGENT trial: computerised decision support guidelines for asthma vs angina care Eccles [@b117]UK primary careMcColl [@b47]OrthopaedicsAdults with non-surgical musculoskeletal condition ≥ 18 years in OMENS trial: orthopaedic patients management from single musculoskeletal medicine physician vs. orthopaedic surgeon-led management Leigh [@b35]UK Hospital othhopaedic outpatient departmentLeigh [@b35]Other areasExerciseWomen sedentary 50-70 years. SWEAT2 trial: moderate walking programme vs. swimming programme Cox [@b15]Australia communityCox [@b15]ParentingAdults referred for parenting mean age 29 years. Parent-child interactive therapy vs. standard didactic parenting condition Chaffin [@b12]USA communityChaffin [@b12]Weight managementAdults with BMI = 25 aged = 18 years. Internet-based tailored weight management materials vs. Internet-based non-tailored user navigated weight management materials Rothert [@b153]USA communityCouper [@b14]Effect of antibiotics on neonatal outcomesWomen \< 37 weeks\' gestation in ORACLE 1 + 2 trial: 2 x 2 factorial: co-amoxiclav + erythromycin vs. co-amoxiclav vs. erythromycin vs. placebo; 4 times daily x 10 days or until birth Kenyon [@b26]UK secondary care/communityKenyon [@b26]Health promotionPeople aged 16-20 years in the sex unzipped pilot feasibility trial: interactive intervention website vs. information only website (main trial unpublished)UK on lineBailey [@b3]\*Health promotionPeople aged 16-20 years in the sex unzipped pilot feasibility trial: interactive intervention website vs. information only website (main trial unpublished)UK on lineBailey [@b4]\*[^4][^5]

CHARACTERISTICS OF STUDIES
==========================

Characteristics of included studies *\[ordered by study ID\]*
-------------------------------------------------------------

Ashby 2011Methods2-arm randomised trialDataAdults aged 18-65 years who provided email or mobile telephone contact details for receiving electronic reminders for follow-up in a migraine prevention trialComparisons1. Electronic reminder: either SMS text message, email message, or both sent after the 4-week follow-up study questionnaire sent 2. No electronic reminder sentOutcomesPrimary: questionnaire response rate defined as proportion of questionnaires returned by participants at final analysis at 40 days Secondary: time to responseNotesRetention trial embedded in a randomised trial evaluating the effectiveness of food elimination diet based on the ELISA test for food sensitivity for prevention of migraine. Primary outcome for the migraine prevention trial (host trial): change in the number of headache days over 12 weeks using the migraine disability assessment questionnaire (MIDAS). Retention trial identified through mail out to UK clinical trials units***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthors response \"an independent data manager at the trials unit was responsible for generating the allocation sequence and assigning participants\"Adequate sequence generation?Unclear\"Randomly generated numbers used to list all participants by ID \[identification\] number who had provided a mobile phone number and/or and email address. The first half of listed participants were allocated to the intervention group the remaining participants were allocated to the control group\"Blinding?UnclearNo reference to blinding of either participants or outcome assessors in the study reportFree of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement Avenell 2004MethodsRandomised trialDataAdults aged ≥ 70 years with a low trauma osteoporotic fracture in the past 10 years recruited in 1 centre of the RECORD trialComparisons1. An open version of the RECORD trial otherwise identical in design 2. RECORD trial, a randomised double-blind placebo-controlled factorial design of oral calcium 1 g daily and or vitamin D 800 IU/20 µg supplementationOutcomesProportion of eligible participants recruited Proportion remaining in the trial at 1 year Proportion compliant on pill counts at 8 monthsNotesOpen version of the Randomised Evaluation of Calcium or Vitamin D (RECORD) Trial treated as the intervention group in the analysis. Proportion retained at 4, 8 and 12 months were reported. Primary outcome for the randomised double-blind placebo-controlled version of the RECORD trial was all new low-energy fractures***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Nurse used a pre programed laptop computer\"Adequate sequence generation?Yes\"A pre programed laptop computer to generate random allocation\"Blinding?YesDouble-blind randomised trial design compared with an open trial design. For the double-blind randomised trial \"allocation remained concealed until the final analyses\". \"All outcomes were reported or verified by people who were masked to the allocation scheme\"Free of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement Bailey 1MethodsRandomised trial embedded in the sex unzipped website feasibility trialDataUK English speaking people aged 16-20 yearsComparisons1. Offer of GBP20 voucher 2. Offer of GBP10 voucherOutcomesRetention of participants at 3-month follow-up, i.e. completion of sexual health surveyNotesRetention trial identified through personal correspondence with the author Sexunzipped website evaluated in an online trial***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthors response \"the trial statisticians generated the randomisation sequence with participants identified by ID \[identification\] number only and the trial manager implemented it manually\"Adequate sequence generation?YesAuthors response \"participants were randomised after recruitment but before follow-up to a GBP10 or GBP20 incentive. Randomisation to increased incentive was through simple permutation of the list of remaining recruits\"Blinding?UnclearAuthors response \"allocation sequences were generated without participants\' knowledge\". \"For those allocated to the increased amount of GBP20, this was revealed in a 3 month follow-up email. Those allocated to GBP10 were not aware that others were offered GBP20 (unless friends had enrolled and had discussed the study). Since the trial recruited participants online from all over the UK, this will have reduced the chance of bias due to contamination\"Free of selective outcome reporting?YesReports the primary outcome Bailey 2MethodsRandomised trialDataUK English speaking people aged 16-20 yearsComparisons1. Offer of GBP20 voucher: GBP10 in advance and GBP10 on receipt of questionnaire and chlamydia kit 2. Offer of GBP10 voucher: GBP5 in advance and GBP5 on receipt of questionnaire and chlamydia kitOutcomesRetention of participants at 3-month follow-up, i.e. completion of sexual health survey and return of chlamydia kitNotesStudy identified through personal correspondence with author Sex unzipped website evaluated in an online trial***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthors response \"the trial statisticians generated the randomisation sequence (with participants identified by ID \[identification\] number only), and the trial manager implemented it manually\"Adequate sequence generation?YesAuthors response \"participants were randomised after recruitment but before follow-up to a GBP10 or GBP20 incentive. Randomisation to increased incentive was through simple permutation of the list of remaining recruits\"Blinding?UnclearAuthors response \"allocation sequences were generated without participants\' knowledge\". \"For those allocated to the increased amount of GBP20, this was revealed in a 3 month follow-up email. Those allocated to GBP10 were not aware that others were offered GBP20 (unless friends had enrolled and had discussed the study). Since the trial recruited participants online from all over the UK, this will have reduced the chance of bias due to contamination\"Free of selective outcome reporting?YesReports the primary outcome Bauer 2004aMethods3-arm randomised trial (first incentive vs. no incentive)DataPilot study of 15 randomly selected participants from each of 20 communities participating in COMMIT trialComparisonsEnclosed with mouthwash swish collection kits sent to participants \"subjects were further randomised to receive\" either: 1. USD10 cheque told to keep the cheque whether or not they participated, sent with covering letter and prepaid envelope 2. No incentive, kit sent with covering letter and prepaid envelope All sent 2 weeks after an advance letter with a professionally rendered brochureOutcomesPercentage of mouthwash kits returned reported. No time point givenNotesStudy embedded in the cluster randomised Community Intervention Trial for Smoking Cessation (COMMIT) trial. Primary outcome: quit rate among heavy smokers. Several attempts to contact authors regarding allocation sequence. Data extracted from Edwards Cochrane review on response to postal questionnaires***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearNo reply from authorAdequate sequence generation?Unclear\"Subjects were further randomised to receive an incentive of.....\"Blinding?UnclearInsufficient information to make a judgement about this, no reply from authorFree of selective outcome reporting?UnclearNo reply from authorOther sources of bias?UnclearInsufficient information to make a judgement Bauer 2004abMethods3-arm randomised trial (combined incentive vs. no incentive)DataPilot study of 15 randomly selected participants from each of 20 communities participating in COMMIT trialComparisonsEnclosed with mouthwash swish collection kits sent to participants \"subjects were further randomised to receive\" either: 1. USD10 cheque told to keep the cheque whether or not they participated sent with covering letter and prepaid envelope or 2. USD2 cheque with covering letter and prepaid envelope or 3. No incentive, kit sent with covering letter and prepaid envelope All sent 2 weeks after an advance letter with a professionally rendered brochureOutcomesPercentage of mouthwash kits returned reported. No time point givenNotesStudy embedded in the cluster randomised Community Intervention Trial for Smoking Cessation (COMMIT) trial. Primary outcome: quit rate among heavy smokers. Several attempts to contact authors regarding allocation sequence. Data extracted from Edwards Cochrane review on response to postal questionnaires***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearNo reply from authorAdequate sequence generation?Unclear\"Subjects were further randomised to receive an incentive of.....\"Blinding?UnclearInsufficient information to make a judgement about this no reply from authorFree of selective outcome reporting?UnclearNo reply from authorOther sources of bias?UnclearInsufficient information to make a judgement Bauer 2004bMethods3-arm randomised trial (second incentive vs. no incentive)DataPilot study of 15 randomly selected participants from each of 20 communities participating in COMMIT trialComparisonsEnclosed with mouthwash swish collection kits sent to participants, \"subjects were further randomised to receive\" either: 1. USD2 check with covering letter and prepaid envelope 2. No incentive, kit sent with covering letter and prepaid envelope All sent 2 weeks after an advance letter with a professionally rendered brochureOutcomesPercentage of mouthwash kits returned reported. No time point givenNotesStudy embedded in the cluster randomised Community Intervention Trial for Smoking Cessation (COMMIT) trial. Primary outcome: quit rate among heavy smokers. Several attempts to contact authors regarding allocation sequence. Data extracted from Edwards Cochrane review on response to postal questionnaires***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearNo reply from authorAdequate sequence generation?Unclear\"Subjects were further randomised to receive an incentive of.....\"Blinding?UnclearInsufficient information to make a judgement about thisFree of selective outcome reporting?UnclearNo reply from authorOther sources of bias?UnclearInsufficient information to make a judgement Bowen 2000aMethodsRandomised 2 x 2 factorial trial (first incentive vs. no incentive)DataAdults aged 50-69 years recruited from 2 CARET trial sites, participating in the Participant Retention Item Distribution Evaluation (PRIDE) trialComparisons1. Certificate of appreciation preprinted on an 8.5 x 11 inch (21.59 x 27.94 cm)bond off-white paper with gold trim and bold, black lettering. The certificate read \"\[participant\'s name\] in recognition of your contribution to an important national study for the prevention of lung cancer, CARET, CancerPrevention Study, sponsored by The National Cancer Institute\". The participant\'s name was computer printed in an attractive font on the certificate. Each certificate had the signatures of the Co-ordinating Center\'s principal investigator, study centre investigator and CARET\'s project officer from the National Cancer Institute, given during a visit for randomisation or follow-up 2. No incentiveOutcomesPrimary: time of first inactivation (stop taking vitamins or placebos) during the 2-year follow-up period of PRIDENotesPrimary disease outcome for the Carotene and Retinol Efficacy Trial (CARET): lung cancer***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearAuthor response \"the Coordination Center supplied one date-labelled envelope for each day in the enrolment period to the two participating study centres. The envelopes contained the randomisation assignment for the given day. At the end of each day during the randomisation period, study centre staff opened the envelope containing the intervention assignment for the next day. Study centre staff members were otherwise blinded to the allocation sequence\"Adequate sequence generation?YesAuthor response \"we used a block randomisation approach (stratified by study centre) with a 1:1:1:1 intervention arm allocation ratio, where the randomisation unit was the date of enrolment\". Note: treated this as quasi-randomised in the analysisBlinding?YesAuthor response \"with IRB \[Institutional Review Board\] approval, the study was conducted without participants\' knowledge of this research. Thus, participants were blinded to their own intervention only in the sense that they were unaware they were randomised to receive particular item(s)\"Free of selective outcome reporting?YesCumulative incidence of individuals who became inactive during 2-year follow-up reportedOther sources of bias?UnclearInsufficient information to make a judgement Bowen 2000abcMethodsRandomised 2 x 2 factorial trial (combined incentive vs. no incentive)DataAdults aged 50-69 years recruited from 2 CARET trial sites, participating in the Participant Retention Item Distribution Evaluation (PRIDE) trialComparisons1. Certificate of appreciation preprinted on an 8.5 x 11 inch (21.59 x 27.94 cm)bond off-white paper with gold trim and bold, black lettering. The certificate read \'\[participant\'s name\] in recognition of your contribution to an important national study for the prevention of lung cancer, CARET, CancerPrevention Study, sponsored by The National Cancer Institute\'. The participant\'s name was computer printed in an attractive font on the certificate. Each certificate had the signatures of the Co-ordinating Center\'s principal investigator, study centre investigator, and CARET\'s project officer from the National Cancer Institute, given during a visit for randomisation or follow-up (arm a) 2. Lapel pin 1 inch (2.5 cm) in size and designed in cloisonne. Choice between a pin with 6 colours with inscription \'CARET NCI prevention study\' and an orange carrot in the middle of the pin or a pin with 5 colours with inscription \'PARTICIPNAT CARET Cancer Prevention Study\' and \'Sponsored by NCI\' and given during a visit for randomisation or follow-up (arm b) 3. Certificate of appreciation (details as before) and lapel pin (details as before) and given during a visit for randomisation or follow-up (arm c) 4. No incentiveOutcomesPrimary: time of first inactivation (stop taking vitamins or placebos) during the 2-year follow-up period of PRIDENotesPrimary disease outcome for the Carotene and Retinol Efficacy Trial (CARET): lung cancer***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearAuthor response \"the Coordination Center supplied one date-labelled envelope for each day in the enrolment period to the two participating study centres. The envelopes contained the randomisation assignment for the given day. At the end of each day during the randomisation period, study centre staff opened the envelope containing the intervention assignment for the next day. Study centre staff members were otherwise blinded to the allocation sequence\"Adequate sequence generation?YesAuthor response \"we used a block randomisation approach (stratified by study centre) with a 1:1:1:1 intervention arm allocation ratio, where the randomisation unit was the date of enrolment\"Blinding?YesAuthor response \"with IRB \[Institutional Review Board\] approval, the study was conducted without participants' knowledge of this research. Thus, participants were blinded to their own intervention only in the sense that they were unaware they were randomised to receive particular item(s)\"Free of selective outcome reporting?YesCumulative incidence of individuals who became inactive during 2 year follow-up reportedOther sources of bias?UnclearInsufficient information to make a judgement Bowen 2000bMethodsRandomised 2 x 2 factorial trial (second incentive vs. no incentive)DataAdults aged 50-69 years recruited from 2 CARET trial sites, participating in the Participant Retention Item Distribution Evaluation (PRIDE) trialComparisons1. Lapel pin 1 inch (2.5 cm) in size and designed in cloisonne. Choice between a pin with 6 colours with inscription \'CARET NCI prevention study\' and an orange carrot in the middle of the pin or a pin with 5 colours with inscription \'PARTICIPNAT CARET Cancer Prevention Study\' and \"Sponsored by NCI\" and given during a visit for randomisation or follow-up 2. No incentiveOutcomesPrimary: time of first inactivation (stop taking vitamins or placebos) during the 2-year follow-up period of PRIDENotesPrimary disease outcome for the Carotene and Retinol Efficacy Trial (CARET): lung cancer***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearAuthor response \"the Coordination Center supplied one date-labelled envelope for each day in the enrolment period to the two participating study centres. The envelopes contained the randomisation assignment for the given day. At the end of each day during the randomisation period, study centre staff opened the envelop containing the intervention assignment for the next day. Study centre staff members were otherwise blinded to the allocation sequence\"Adequate sequence generation?YesAuthor response \"we used a block randomisation approach (stratified by study centre) with a 1:1:1:1 intervention arm allocation ratio, where the randomisation unit was the date of enrolment\"Blinding?YesAuthor response \"with IRB \[Institutional Review Board\] approval, the study was conducted without participants' knowledge of this research. Thus, participants were blinded to their own intervention only in the sense that they were unaware they were randomised to receive particular item(s)\"Free of selective outcome reporting?YesCumulative incidence of individuals who became inactive during 2-year follow-up reportedOther sources of bias?UnclearInsufficient information to make a judgement Bowen 2000cMethodsRandomised 2 x 2 factorial trial (third incentive vs. no incentive)DataAdults aged 50-69 years recruited from 2 CARET trial sites, participating in the Participant Retention Item Distribution Evaluation (PRIDE) trialComparisons1. Certificate of appreciation (details as before) **and** lapel pin (details as before) and given during a visit for randomisation or follow-up 2. No incentiveOutcomesPrimary: time of first inactivation (stop taking vitamins or placebos) during the 2-year follow-up period of PRIDENotesPrimary disease outcome for the Carotene and Retinol Efficacy Trial (CARET): lung cancer***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearAuthor response \"the Coordination Center supplied one date-labelled envelope for each day in the enrolment period to the two participating study centres. The envelopes contained the randomisation assignment for the given day. At the end of each day during the randomisation period, study centre staff opened the envelop containing the intervention assignment for the next day. Study centre staff members were otherwise blinded to the allocation sequence\"Adequate sequence generation?YesAuthor response \"we used a block randomisation approach (stratified by study centre) with a 1:1:1:1 intervention arm allocation ratio, where the randomisation unit was the date of enrolment\"Blinding?YesAuthor response \"with IRB \[Institutional Review Board\] approval, the study was conducted without participants' knowledge of this research. Thus, participants were blinded to their own intervention only in the sense that they were unaware they were randomised to receive particular item(s)\"Free of selective outcome reporting?YesCumulative incidence of individuals who became inactive during 2-year follow-up reportedOther sources of bias?UnclearInsufficient information to make a judgement Chaffin 2009Methods2-arm randomised trialDataAll parents referred for parenting services at a small inter-city non-profit community agency operating a parenting programmeComparisons1. Initial preparenting orientation condition self motivation group 2. Initial preparenting orientation condition standard informational groupOutcomesDropout from the parenting group at 12 weeksNotesA second randomisation was performed after completion of the orientation programme to parent child interactive therapy vs. standard didactic parenting condition. Dropout recorded at 2-week intervals up to 12 weeks***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?No\"Unblinded randomisation list\"Adequate sequence generation?Yes\"Computer generated randomisation list\"Blinding?YesAuthor response \"they (parents) were informed only in general terms that we were interested in which types of services helped\". Participant interviews were conducted by computer. Blinding of personnel: observational parent-child interaction coding was done by personnel who were not informed about intervention condition assignmentFree of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?No\"It is possible that therapist effects may have played a role in the outcomes\" Cockayne 2005Methods2-arm randomised trialDataWomen aged ≥ 70 years randomised at 1 centre for a fracture prevention trial due to receive their final follow-up questionnaire in March 2004Comparisons1. Final follow-up questionnaire additional question offering results of the trial delivered by post 2. Final follow-up questionnaire no offer of study results delivered by post Both groups received a personalised cover letter showing university sponsorship, along with a business reply envelope. Non-responders within 3 weeks were sent up to 2 reminder letters, questionnaires and business reply envelopes, 3 and 6 weeks after the initial mailingOutcomesReturn of final follow-up questionnaire by participants. Time point not specifiedNotesAuthors contacted to confirm numbers randomised to each arm The Fracture Prevention Trial: calcium 1000 mg plus vitamin D~3~ 800 IU plus information sheet on dietary calcium intake and falls prevention vs. information sheet. Primary outcome for the fracture prevention trial: all clinical fractures excluding those of the digits, rib, face and skull***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"An independent researcher from the York trials unit randomised eligible women\"Adequate sequence generation?Yes\"Randomised eligible women in a 3:1 ratio by computer\"Blinding?Unclear\"Administration of the questionnaire was not blind to the group allocation\"Free of selective outcome reporting?YesAll outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement Couper 2007Methods2-arm randomised trial (incentive plus postal questionnaire vs. telephone survey)DataAdults ≥ 18 years, BMI of ≥ 25 participating in an Internet-based weight management trial who did not respond to the 12-month questionnaireComparisons1. Telephone call and survey by trained interviewers. Repeated up to 15 times. Attempts made on various days and at various times of the day 2. Postal questionnaire with return address and covering letter signed by directors plus a USD5 billOutcomesQuestionnaire response. No time point givenNotesInternet-based weight management trial compared Internet-based tailored weight management materials with Internet-based non-tailored user navigated weight management materials. Primary outcome for the Internet-based trial: percentage of baseline weight lost***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearNot describedAdequate sequence generation?UnclearAuthor response \"randomly assigned\"Blinding?UnclearNot describedFree of selective outcome reporting?UnclearUnclear at the outset what is to be reportedOther sources of bias?UnclearInsufficient information to make a judgement Cox 2008Methods2-arm randomised trialDataAll sedentary women aged 50-70 years participating in the SWEAT2 trialComparisons1. 12 work sheets with strategies for goal setting, time management and overcoming barriers to attendance, mini workshops, received worksheets to complete at home - after 6 months received newsletters only. Intervention delivered by a trained facilitator, before an exercise session 2. Information sheets about programme requirements exercise techniques, safety plus 9 newsletters and a report on fitness at 6 months delivered by principle investigator plus 9 newslettersOutcomesProgramme retention at 6 and 12 monthsNotesContact with authors to clarify if withdrawals occurred before or after randomisation SWEAT2 compared moderate walking programme vs. swimming programme. Primary outcome adherence to the programme***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Computer generated random numbers by a statistician\"Adequate sequence generation?Yes\"Computer generated random numbers\"Blinding?Unclear\"Not practical to blind the participants or the research staff to the group assignment\" (see other sources of bias below)Free of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?Yes\"Walk and swim sessions were not separated according to the behavioural intervention participants asked not to discuss written materials in the practical sessions\" Dorman 1997Methods2-arm randomised trialDataAll UK participants entered into the International Stroke Trial between 2 March 1993 and 31 May 1995 who were still aliveComparisons1. Short EuroQol posted with personalised letter and reply paid envelope. 1 reminder sent after 2 weeks 2. Long SF36 questionnaire posted with personalised letter and reply paid envelope. 1 reminder sent after 2 weeksOutcomesFrequency of response after first and reminder mail out. Data for response to first mail out usedNotesInternational Stroke Trial compared heparin 125,000 IU twice daily + aspirin 300 mg vs. heparin 125,000 IU twice daily; heparin 5000 IU twice daily + aspirin 300 mg daily vs. heparin 5000 IU twice daily vs. aspirin 300 mg daily vs. no heparin or aspirin. Primary outcome: death within 14 days or dependency at 6 months***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthors response \"generated by computer\"Adequate sequence generation?UnclearAuthor response \"generated by computer\"Blinding?UnclearAuthors report \"there was no blinding for either study staff or participants\"Free of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement Edwards 2001Methods2-arm randomised trialDataAdults aged ≥ 16 years with head injury in the UK CRASH trialComparisons1. 1-page, 7-question functional dependence questionnaire with covering letter and stamped return envelope. Reminders after 4 and 8 weeks 2. 3-page, 16-question functional dependence questionnaire with covering letter and stamped return envelope. Reminders after 4 and 8 weeksOutcomesNo of questionnaires returned within 3 monthsNotesAuthors provided numbers randomised and responded Primary outcome for the CRASH: death from any cause within 2 weeks of injury and death or disability at 6 months***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Central computer\"Adequate sequence generation?Unclear\"Central computer\"Blinding?UnclearAuthor response \"questionnaires were packaged and sent to patients by personnel who were independent of the study\"Free of selective outcome reporting?YesReported non-responseOther sources of bias?UnclearInsufficient information to make a judgement Ford 2006Methods2-arm quasi-randomised trialDataAfrican American men aged 55 years enrolled in the intervention screening arm of the PLCO trialComparisons1. Indepth case management. Case management monthly telephone calls to participants, assisted making medical appointments, helped participants obtain health insurance information, legal aid, transportation services, food programmes, financial support, medication assistance, free medical care, information related to health risks facing African Americans. Provision of PLCO Cancer Screening Trial screening information and the scheduling of annual screening appointments. 2. Regular trial screening procedures. Participants called annually to schedule screening examinationsOutcomesNumber completing the next scheduled PLCO cancer screen at 3 yearsNotesPLCO trial compared digital rectal examination, transvaginal ultrasound and chest x-ray at baseline and 5 years to usual follow-up. PSA and cancer antigen CA125 at baseline, and annually for 5 years. Primary outcome mortality from 4 PLCO cancers***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearNot describedAdequate sequence generation?No\"Randomised by participant id number\"Blinding?UnclearInsufficient information to make a judgement about thisFree of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Gates 2009Methods2-arm quasi-randomised trialDataAll participants enrolled in the MINT trial due a follow-up questionnaire at 4 or 8 months after whiplash injuryComparisons1. GBP5 voucher redeemable at shops www.highstreetvouchers.com plus questionnaire, cover letter included a sentence explaining that the voucher is to thank participants for their time and effort, delivered by post 2. No voucher and a standard covering letter with the questionnaireOutcomesNumber of questionnaires returned after first contact with participantsNotesNumber of questionnaires returned in the incentive arm checked with authors Primary outcome for the Managing Injuries of the Neck Trial (MINT) was returned to normal after whiplash injury measured using the Neck Disability Index (NDI)***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearAuthor response \"lack of concealment of allocations before randomisation was not a major concern because it would have been very difficult for the staff in the study office who were sending out the questionnaires to have selectively allocated systematically different patients to the trial arm\"Adequate sequence generation?NoAuthor response \"allocation to study arms was according to whether a specific digit of the patients study number was odd or even\"Blinding?UnclearAuthor response \"trial office staff were unblinded, they had no influence over any participant\'s decision to return the questionnaire, and postal and telephone follow-up contacts were performed in a standardised way for all participants, without any reference to whether or not they were participating in the incentive study\"Free of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Hughes 1989Methods2-arm randomised trialDataAll smokers for = 1 year in the nicotine gum vs. placebo gum trialComparisons1. A letter promising a free reprint of the study results in return for sending in the questionnaire 2. No offer of resultsOutcomesQuestionnaire response. No time point givenNotesAuthor contacted regarding numbers randomised Nicotine gum trial was double blind. The primary outcome was alleviation of signs and symptoms of tobacco withdrawal measured using a rating list and POMS (profile of mood states) questionnaire and DSM III criteria for tobacco withdrawal***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"by a non involved researcher sequence in sealed envelope, never opened during study\"Adequate sequence generation?YesAuthor response \"using a table of random numbers\"Blinding?UnclearAuthor response \"participants fully aware of each condition and which they were in\"Free of selective outcome reporting?YesResponse rates reportedOther sources of bias?UnclearInsufficient evidence to make a judgement on this Kenton 2007aMethodsRandomised 2 x 2 factorial trial (incentive vs. offer of incentive)DataNew mothers with Edinburgh postnatal depression scale score = 9 participating in postpartum depression peer support trialComparisons1. USD2 coin mailed with questionnaire 2. Offer of entry into prize draw for USD50 gift certificateOutcomesQuestionnaire response. No time point givenNotesThe postpartum depression peer support trial enrolled women \< 2 weeks\' postpartum at high risk for postnatal depression. New proactive individualised telephone-based peer support with standard postpartum care. The primary outcome was postnatal depression measured using the Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"allocation sequence stored in a password protected file only accessed by an external researcher, computer generated\"Adequate sequence generation?UnclearAuthor response \"computer generated\"Blinding?YesAuthor response \"participants were not aware of the sub-study and didn\'t know other participants were receiving different types of mailings. The trial coordinator was not blinded to the study group\"Free of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Kenton 2007a-dMethodsRandomised 2 x 2 factorial trialDataNew mothers with Edinburgh, postnatal depression scale score = 9 participating in postpartum depression peer support trialComparisons1. USD2 coin mailed with questionnaire 2. Offer of entry into prize draw for USD50 gift certificate 3. USD2 coin with questionnaire sent with high-priority postage stamp 4. Offer of entry into lottery draw for USD50 gift certificate with high-priority postage stampOutcomesQuestionnaire response. No time point givenNotesThe postpartum depression peer support trial enrolled women \< 2 weeks\' postpartum at high risk for postnatal depression. New proactive individualised telephone-based peer support with standard postpartum care. The primary outcome was postnatal depression measured using the Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"allocation sequence stored in a password protected file only accessed by an external researcher, computer generated\"Adequate sequence generation?UnclearAuthor response \"computer generated\"Blinding?YesAuthor response \"participants were not aware of the sub-study and didn\'t know other participants were receiving different types of mailings. The trial coordinator was not blinded to the study group\"Free of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Kenton 2007bMethodsRandomised 2 x 2 factorial trial (incentive + priority mail vs. offer of incentive + priority mail)DataNew mothers with Edinburgh postnatal depression scale score = 9 participating in postpartum depression peer support trialComparisons1. USD2 coin with questionnaire sent with high-priority postage stamp 2. Offer of entry into lottery draw for USD50 gift certificate with high-priority postage stampOutcomesQuestionnaire response. No time point givenNotesThe postpartum depression peer support trial enrolled women \< 2 weeks\' postpartum at high risk for postnatal depression. New proactive individualised telephone-based peer support with standard postpartum care. The primary outcome was postnatal depression measured using the Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID).***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"allocation sequence stored in a password protected file only accessed by an external researcher, computer generated\"Adequate sequence generation?UnclearAuthor response \"computer generated\"Blinding?YesAuthor response \" participants were not aware of the sub-study and didn\'t know other participants were receiving different types of mailings. The trial coordinator was not blinded to the study group\"Free of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Kenton 2007cMethodsRandomised 2 x 2 factorial trial (priority mail vs. no priority mail)DataNew mothers with Edinburgh postnatal depression scale score = 9 participating in postpartum depression peer support trialComparisons1. USD2 coin sent by high-priority postage stamp plus questionnaire 2. USD2 coin plus questionnaireOutcomesQuestionnaire response. No time point givenNotesThe postpartum depression peer support trial enrolled women \< 2 week\' postpartum at high risk for postnatal depression. New proactive individualised telephone-based peer support with standard postpartum care. The primary outcome was postnatal depression measured using the Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"allocation sequence stored in a password protected file only accessed by an external researcher, computer generated\"Adequate sequence generation?UnclearAuthor response \"computer generated\"Blinding?YesAuthor response \"participants were not aware of the sub-study and didn\'t know other participants were receiving different types of mailings. The trial coordinator was not blinded to the study group\"Free of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Kenton 2007dMethodsRandomised 2 x 2 factorial trial (offer of entry into prize draw plus high-priority postage stamp vs. offer of entry into prize draw)DataNew mothers with Edinburgh postnatal depression scale score = 9 participating in postpartum depression peer support trialComparisons1. Offer of entry into prize draw for USD50 gift certificate plus high-priority postage stamp 2. Offer of entry into prize draw for USD50 gift certificateOutcomesQuestionnaire response. No time point givenNotesThe postpartum depression peer support trial enrolled women \< 2 weeks\' postpartum at high risk for postnatal depression. New proactive individualised telephone-based peer support with standard postpartum care. The primary outcome was postnatal depression measured using the Edinburgh postnatal depression scale and Structured Clinical Interview Depression (SCID)***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"allocation sequence stored in a password protected file only accessed by an external researcher, computer generated\"Adequate sequence generation?UnclearAuthor response \"computer generated\"Blinding?YesAuthor response \"participants were not aware of the sub-study and didn\'t know other participants were receiving different types of mailings. The trial coordinator was not blinded to the study group\"Free of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Kenyon 2005Methods2-arm randomised trialDataWomen in ORACLE 1 and 2 participating in the evaluation of health and development studyComparisons1. GBP5 voucher mailed with questionnaire redeemable at many high street shops 2. No incentiveOutcomesQuestionnaire response rate. No time point givenNotesORACLE trial: women with preterm prelabour rupture of fetal membranes and women with intact membranes in preterm labour, randomised to erythromycin 250 mg, co-amoxiclav 325 mg, erythromycin 250 mg plus co-amoxiclav 325 mg or placebo x 10 days or until birth. Primary outcome composite of neonatal death, chronic lung disease or major cerebral abnormality before discharge from hospital***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Randomly assigned by concealed computer generated allocation\"Adequate sequence generation?Yes\"Randomly assigned by \"computer\" \"Blinding?YesAuthor response \"both the participants and the study personnel were blinded to the allocation\"Free of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Khadjesari 2011MethodsKhadjesari 1: 4-arm randomised trial Khadjesari 2: 2-arm randomised trialDataSee \'Table of characteristics\' for Khadjesari [@b29]; Khadjesari [@b33]ComparisonsSee \'Table of characteristics\' for Khadjesari [@b29]; Khadjesari [@b33]OutcomesSee \'Table of characteristics\' for Khadjesari [@b29]; Khadjesari [@b33]NotesSee \'Table of characteristics\' for Khadjesari [@b29]; Khadjesari [@b33]***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed\", \"randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesAll outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Khadjesari 2011 1aMethods4-arm randomised trial (offer of incentives vs. no offer)DataNon-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire. Adults aged ≥ 18 scoring 5 or more on the AUDIT-C testComparisons1. Offer of GBP5 Amazon.co.uk voucher. Emailed voucher code on receipt of response (arm a) 2. Email with no offer of incentive (control)OutcomesProportion completing questionnaire after 40 daysNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Khadjesari 2011 1abcMethods4-arm randomised trialDataNon-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire. Adults aged ≥ 18 scoring 5 or more on the AUDIT-C testComparisons1. Offer of GBP5 Amazon.co.uk voucher. Emailed voucher code on receipt of response (arm a) 2. Offer of GBP5 donation to Cancer Research UK. Emailed hyperlink to charity\'s website showing donation when response received (arm b) 3. Offer of entry into GBP250 prize draw emailed confirmation of entry when response received (arm c) 4. Email prompt for completion of questionnaires with no offer of incentive (control arm)OutcomesProportion completing questionnaire after 40 daysNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Khadjesari 2011 1acMethods4-arm randomised trial (incentives combined vs. no incentive)DataNon-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire. Adults aged ≥ 18 scoring 5 or more on the AUDIT-C testComparisons1. Offer of GBP5 Amazon.co.uk voucher. Emailed voucher code on receipt of response (arm a) 2.Offer of entry into GBP250 prize draw emailed confirmation of entry when response received (arm c) 3. Email with no offer of incentive (control arm)OutcomesProportion completing questionnaire after 40 daysNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication Separate comparison for arm b of attrition trial see Khadjesari [@b31]***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Khadjesari 2011 1bMethods4-arm randomised trial (offer of donation to charity vs. no offer)DataNon-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire. Adults aged ≥ 18 scoring 5 or more on the AUDIT-C testComparisons1. Offer of GBP5 donation to Cancer Research UK. Emailed hyperlink to charity\'s website showing donation when response received (arm b) 2. Email with no offer of incentive (control)OutcomesProportion completing questionnaire after 40 daysNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Khadjesari 2011 1cMethods4-arm randomised trial (offer of entry into prize draw vs. no offer)DataNon-responders at 1 week to the pilot DYD trial 3-month online follow-up questionnaire. Adults aged ≥ 18 scoring 5 or more on the AUDIT-C testComparisons1. Offer of entry into GBP250 prize draw emailed confirmation of entry when response received (arm c) 2. Email with no offer of incentive (control arm)OutcomesProportion completing questionnaire after 40 daysNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Khadjesari 2011 2Methods2-arm randomised trialDataAll DYD trial study participantsComparisons1. Offer of a GBP10 Amazon.co.uk voucher. Email with voucher code sent on completion of questionnaire 2. Reminder email with no voucher offerOutcomesThe proportion of participants that completed the questionnaire after 40 daysNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed\", \"randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesAll outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Land 2007Methods2-arm randomised trialDataResearch sites participating in the NSABP B35 trialComparisons1. Automated prospective monthly reminder to trial sites of upcoming participant-reported outcome assessments. Reminder listed participants expected to complete Behavioral and Health Outcomes forms in upcoming 3 months 2. No monthly assessment reminderOutcomesReceipt of questionnaire at any timeNotesB35 Anastrozole vs. tamoxifen for the treatment of ductal carcinoma in situ women aged 55 years plus. Primary outcome: time to first breast cancer reoccurrence***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearAuthor response to question \"describe the methods if any, used to conceal the allocation sequence for the prospective reminder study in B35\", \"not applicable. Institutions were all randomly assigned before trial initiation, so there was no sequence\"Adequate sequence generation?YesAuthor response \"prospective reminder in B-35, three strata were generated, and half in each were randomly assigned to receive the reminder\"Blinding?NoAuthor response \"there was no blinding the prospective reminder was received by clinical staff\"Free of selective outcome reporting?YesPrimary outcome reportedOther sources of bias?UnclearInsufficient information to make a judgement Leigh Brown 1997Methods2-arm randomised trialDataParticipants in OMENS due to receive follow-up questionnaires between March and December 1995Comparisons1. Offer of GBP25 gift voucher monthly prize draw. Postcard reminder after 10 days and 3 weeks with reference to offer 2. No offer. Post card reminders after 10 days and 3 weeks with no reference to offerOutcomesQuestionnaire response. No time point givenNotesOMENS effectiveness of musculoskeletal medicine vs. care by orthopaedic surgeon-led services for the treatment of non-surgical orthopaedic outpatients Primary outcomes: change in participant reported health (SF-36 and EuroQol) and marginal health***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?NoAuthor response \"table of random numbers\"Adequate sequence generation?YesAuthor response \"table of random numbers\"Blinding?UnclearAuthor response \"those randomised to take part in the prize draw were aware of the intervention and those randomised to be excluded from the draw were unaware. The trial team were aware of the allocation so that they could arrange the monthly draw\"Free of selective outcome reporting?YesDefined outcomes reported outcome reportedOther sources of bias?UnclearInsufficient evidence to make a judgement about this Letley 2000Methods2-arm randomised trialDataParticipants in the UKBEAM feasibility trial, aged 18-65 years with low back pain and a score of 4 or more on the RDQComparisonsReview author (VB) checked which was control and which was intervention 1. RDQ before SF-36in a 26-page questionnaire 2. SF-36 before RDQ in a 26-page questionnaireOutcomesQuestionnaire response at 3 monthsNotesStudy complete, no data available at 8 September 2011. UKBEAM: compared the effectiveness of exercise, manipulation, exercise and manipulation. Primary outcome for UKBEAM scores on the RDQ at 3 and 12 months***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor reported \"sequence generation was via remote service ensuring allocation concealment\"Adequate sequence generation?YesAuthor reported \"sequence generation was random using randomised permuted blocks\"Blinding?UnclearNo dataFree of selective outcome reporting?YesOverall response rates reportedOther sources of bias?UnclearNo data MacLennanMethods2-arm randomised trialDataParticipants who had not returned questionnaires at 12, 24 and 36 months in the RECORD trialComparisons1. Telephone call from RECORD office before first reminder questionnaire sent. Participant asked to complete questionnaire and to try to fill in all questions. Further telephone call from study nurse or RECORD office if not returned after 3 weeks 2. Repeat mailing of usual follow-up letter and questionnaire. Telephone call by study nurse or RECORD office if not returned after 3 weeks (routine follow-up)OutcomesProportion of first reminder questionnaires returned Proportion of questionnaires returned at 4 months Completeness of dataNotesPrimary outcome all new low-energy fractures (self reported) EQ-5D Short form-12. Trial identified through mail out to UK clinical trial units***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"central randomisation service\"Adequate sequence generation?YesAuthor response \"randomised to receive the \"intervention\" or not using the central randomisation service\"Blinding?YesAuthor response \"blinding was not possible in the \"intervention\" arm. The control were blinded. Trial staff phoning were not blinded. Outcome assessment in the sub-study was objective: questionnaire returned yes/no. Trial staff and trial participants were blinded to the RECORD trial allocation\"Free of selective outcome reporting?YesAll defined outcomes reported Man 2011Methods2-arm randomised trialDataAdults 18-65 years sent a 6-month follow-up questionnaire in a trial of yoga for chronic back painComparisons1. SMS text message: \"Yoga trial: You should receive a questionnaire any day now. The data is important to us so please return it as soon as you can. Many thanks\" 2. Email message: \"Thank you for taking part in the Yoga for Low Back Pain Trial. This is an automatic reminder. You should receive your six month questionnaire any day now. The answers you give in the questionnaire are very important to the trial. Therefore, we should be most grateful if you would complete and return the questionnaire (and any other documents) as soon as possible please. Thank you\" 3. SMS text message plus email message 4. No SMS test message or email messageOutcomesPostal questionnaire responseNotesYoga for chronic back pain trial: primary outcome functional limitations and disability measured by the RDQ. Setting 13 non-national health service settings in the UK. Participants were recruited through general practices***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesComputer-generated sequence to randomly allocate participantsAdequate sequence generation?YesIndependent data manager generated a computer sequenceBlinding?UnclearNo dataFree of selective outcome reporting?YesReported response to questionnairesOther sources of bias?UnclearNo data Marson 2007Methods2-arm randomised trialDataParticipants in SANAD due a QoL questionnaire at 1 yearComparisons1. Cover letter with estimate of the length of time required to complete questionnaire 2. Standard cover letter without estimate of the length of time required to complete questionnaireOutcomesResponse rate. No time point givenNotesSANAD compared the long-term effects of antiepileptic drugs in people with epilepsy. Participants randomised to arm a received carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate and valproate, lamotrigine, or arm B received topiramate. Primary outcome time to treatment failure and time to achieve a 12-month remission of seizures***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?NoAuthor response \"the list was given to the study researcher who worked sequentially through the list from left to right from top to bottom\"Adequate sequence generation?YesAuthor response \"list of allocations was generated electronically using random permuted blocks of length 20\"Blinding?YesAuthor response \"this was a postal study, blinding was not necessary for participants; they received either a time-framed letter or non time-framed letter. Clinical personnel did not see the letters, as these were sent postally directly to participants from the study research office\"Free of selective outcome reporting?YesAttrition reportedOther sources of bias?UnclearInsufficient evidence to make a judgement about this McCambridge 2011MethodsMcCambridge 1: 4-arm randomised trial in the pilot phase of the DYD trial; McCambridge 2: 4-arm randomised trial in the host DYD trialDataSee \'Table of characteristics\' for McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46]ComparisonsSee \'Table of characteristics\' for McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46]OutcomesSee \'Table of characteristics\' for McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46]NotesSee \'Table of characteristics\' for McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46]***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesSee \'Risk of bias\' table McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46]Adequate sequence generation?YesSee \'Risk of bias\' table McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46]Blinding?UnclearSee \'Risk of bias\' table McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46]Free of selective outcome reporting?YesSee \'Risk of bias\' table McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46]Other sources of bias?UnclearSee \'Risk of bias\' table McCambridge [@b41]; McCambridge [@b42]; McCambridge [@b43]; McCambridge [@b44]; McCambridge [@b45]; McCambridge [@b46] McCambridge 2011 1Methods4-arm randomised trial in the pilot phase of the DYD trialDataAdults aged ≥ 18 years scoring ≥ 5 on the AUDIT-C test participating in the pilot phase of the DYD trial 1-month data usedComparisons1. APQ 23 items 2. AUDIT 10 3. LDQ 10 4. CORE-OM 23/34 items (mental health assessment)OutcomesResponse to electronic questionnairesNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this McCambridge 2011 1aMethods4-arm randomised trial (\'relevance\' of questionnaire: alcohol vs. mental health data)DataAdults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the pilot phase of the DYD trial 1-month data usedComparisons1. APQ 23 items 2. CORE-OM 23/34 items (Mental health assessment)OutcomesResponse to electronic questionnairesNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this McCambridge 2011 1bMethods4-arm randomised trial (short vs. long questionnaire comparison)DataAdults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the DYD trial. For this comparison 1-month follow-up data from McCambridge [@b41] usedComparisons1. AUDIT 10 items + LDQ 10 items 2. APQ 23 itemsOutcomesResponse to electronic questionnairesNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this McCambridge 2011 2Methods4-arm randomised trial in the host DYD trialDataAdults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the pilot phase of the DYD trial 3-month data usedComparisons1. APQ 23 items 2. AUDIT 10 3. LDQ 10 4. CORE-OM 23/34 items (Mental health assessment)OutcomesResponse to electronic questionnairesNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this McCambridge 2011 2aMethods4-arm randomised trial (\'relevance\' of questionnaire alcohol vs. mental health)DataAdults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the DYD trial. For this comparison 3-month follow-up data from McCambridge [@b44] usedComparisons1. AUDIT 10 items + LDQ 10 items 2. CORE-10OutcomesResponse to electronic questionnairesNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this McCambridge 2011 2bMethods4-arm randomised trial (short vs. long questionnaire)DataAdults aged ≥ 18 years scoring 5 or more on the AUDIT-C test participating in the DYD trial. For this comparison, 3-month follow-up data from McCambridge [@b44] usedComparisons1. AUDIT 10 items + LDQ 10 items 2. APQ 23 itemsOutcomesResponse to electronic questionnairesNotesPrimary outcome for DYD: total past week alcohol consumption measured using the TOT-AL measure of total alcohol consumption. Trial identified through personal communication***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Allocation was concealed randomisation could not be subverted by the study team\"Adequate sequence generation?YesComputer-generated randomisation sequenceBlinding?UnclearUnclearFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this McColl 2003Methods2-arm randomised trialData40 adults aged ≥ 18 years with asthma from 62 general practices participating in the COGENT trialComparisonsSee \'Table of characteristics\' for McColl [@b48]; McColl [@b49]OutcomesSee \'Table of characteristics\' for McColl [@b48]; McColl [@b49]NotesSee \'Table of characteristics\' for McColl [@b48]; McColl [@b49]***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?NoSee \'Risk of bias\' table McColl [@b48]; McColl [@b49]Adequate sequence generation?UnclearSee \'Risk of bias\' table McColl [@b48]; McColl [@b49]Blinding?YesSee \'Risk of bias\' table McColl [@b48]; McColl [@b49]Free of selective outcome reporting?YesSee \'Risk of bias\' table McColl [@b48]; McColl [@b49]Other sources of bias?UnclearSee \'Risk of bias\' table McColl [@b48]; McColl [@b49] McColl 2003 1Methods2-arm randomised trialData40 adults aged ≥ 18 years with asthma from 62 general practices participating in the COGENT trialComparisons1. Asthma specific instruments (NASQ and AQLQ) followed by generic questions in medical outcomes SF-36 version 1 and EQ-5D 2. Generic questions followed by condition specificOutcomesQuestionnaire response rates, speed and patterns. No time point givenNotesCOGENT before and after cluster randomised, 2 x 2 factorial trial. Evaluated use of computerised support system for decision making for implementing evidenced-based clinical guidelines for the management of asthma (and angina see McColl [@b49]). General practices randomised to computerised guidelines for the management of angina or asthma. Primary outcome adherence to guidelines***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?NoAuthor response \"practices provided us with a computerised list of all patients fulfilling eligibility criteria. We drew a simple random sample of patients from that list first 40 from list received version 1, second 40 version 2\"Adequate sequence generation?UnclearAuthor response \"practices provided us with a computerised list of all patients fulfilling eligibility criteria. We drew a simple random sample of patients from that list. First 40 received version 1, second 40 version 2. Logistically, truly random allocation of the 80 patients to versions 1 and 2 would have been impractical to implement\"Blinding?YesAuthor response \"respondents were not alerted to the fact that we were experimenting with the order of instruments\"Free of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient evidence to make a judgement about this McColl 2003 2Methods2-arm randomised trialData40 adults aged ≥ 18 years with asthma from 62 general practices participating in the COGENT trialComparisons1. Angina-specific instruments (SAQ) followed by generic questions (SF-36 version 1 and EQ-5D) 2. Generic questions followed by condition-specific questionsOutcomesQuestionnaire response rates, speed and patterns. No time point givenNotesCOGENT before and after cluster randomised, 2 x 2 factorial trial. Evaluated use of computerised support system for decision making for implementing evidenced-based clinical guidelines for the management of angina (and asthma see McColl [@b48]). General practices randomised to computerised guidelines for the management of angina or asthma. Primary outcome adherence to guidelines***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?NoAuthor response \"practices provided us with a computerised list of all patients fulfilling eligibility criteria. We drew a simple random sample of patients from that list. First 40 from list received version 1, second 40 version 2\"Adequate sequence generation?UnclearAuthor response \"practices provided us with a computerised list of all patients fulfilling eligibility criteria. We drew a simple random sample of patients from that list. First 40 received version 1, second 40 version 2. Logistically, truly random allocation of the 80 patients to versions 1 and 2 would have been impractical to implement\"Blinding?YesAuthor response \"respondents were not alerted to the fact that we were experimenting with the order of instruments\"Free of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient evidence to make a judgement about this Nakash 2007Methods2-arm randomised trialDataParticipants aged ≥ 16 years from 5 trial centres randomised to CAST between November 2003 and July 2005Comparisons1. Trial calendar: monthly customised calendar, included prenotification caption on the months the participant is due to receive the questionnaire with reminder caption the following month 2. No trial calendarOutcomesQuestionnaire response at 4, 12 weeks and 9 months. Response at 4 weeks used for analysis Amount of prompting required to return questionnaires at each time point Percentage of missing data of the core outcomeNotesCAST tubular bandage, below knee cast, Aircast® ankle brace and Bledsoe® boot compared in people with acute severe ankle sprain. Primary outcome FAOS, FLP, SF-12 and EuroQol 5***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Yes\"Baseline packs compiled in advance and stored at trial sites. On randomisation the next consecutively numbered pack was taken. Allocation concealed until participant recruited into CAST and pack opened\"Adequate sequence generation?Yes\"Computer generated random sequence\"Blinding?Yes\"No blinding of participants or clinic staff\", \"data inputting was blind to allocation\"Free of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient evidence to make a judgement about this Renfroe 2002aMethods2 x 2 x 2 x 2 factorial randomised trial (certificate of appreciation vs. no certificate)DataAll surviving participants at AVID study terminationComparisons1. Certificate of appreciation with cover letter signed by physician or co-ordinator sent either by express or standard post, 2-3 weeks after last AVID follow-up visit or 1-4 months after last AVID follow-up visit 2. No certificate with cover letter signed by physician or co-ordinator, sent either by express or standard post, 2-3 weeks after last AVID follow-up visit or 1-4 months after last AVID follow-up visitOutcomesQuestionnaire response. No time point givenNotesAVID conducted in people resuscitated from ventricular fibrillation or cardioverted for ventricular tachycardia. Compared implanted cardioverter defibrillator vs. antiarrhythmic drugs. Primary outcome overall mortality***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearThe AVID CTC prepared the resulting 16 sets of distinct participant survey packets. These participant-specific packets were then mailed to the study co-ordinators, who distributed them to participants as instructedAdequate sequence generation?YesAuthor response \"all patients in the study were randomised. Details of the randomisation scheme are no longer extant, but given the factorial design I think it\'s safe to assume that the randomization for each factor was by permuted blocks of size 2\"Blinding?YesParticipants were instructed to mail the completed surveys directly to the CTC in postage-paid, self-addressed return envelopes. Only their AVID study number identified participants, assuring confidentiality of their survey responsesFree of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Renfroe 2002a-dMethods2 x 2 x 2 x 2 factorial randomised trialDataAll surviving participants at AVID study terminationComparisons1. Certificate of appreciation 2. No certificate of appreciation 3. Overnight express delivery 4. Regular post 5. Cover letter signed by physician 6. Cover letter signed by study co-ordinator 7. Early administration 8. Late administrationOutcomesQuestionnaire response. No time point givenNotesAVID conducted in people resuscitated from ventricular fibrillation or cardioverted for ventricular tachycardia. Compared implanted cardioverter defibrillator vs. antiarrhythmic drugs. Primary outcome overall mortality***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearThe AVID CTC prepared the resulting 16 sets of distinct participant survey packets. These participant-specific packets were then mailed to the study co-ordinators, who distributed them to participants as instructedAdequate sequence generation?YesAuthor response \"all patients in the study were randomised. Details of the randomisation scheme are no longer extant, but given the factorial design I think it\'s safe to assume that the randomization for each factor was by permuted blocks of size 2\"Blinding?YesParticipants were instructed to mail the completed surveys directly to the CTC in postage-paid, self addressed return envelopes. Only their AVID study number identified participants, assuring confidentiality of their survey responsesFree of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Renfroe 2002bMethods2 x 2 x 2 x 2 factorial randomised trial (express vs. regular post)DataAll surviving participants at AVID study terminationComparisons1. Overnight express delivery with cover letter signed by physician or co-ordinator with or without a certificate of appreciation 2-3 weeks after last AVID follow-up visit or 1-4 months after last AVID follow-up visit 2. Regular post with cover letter signed by physician or co-ordinator with or without a certificate of appreciation 2-3 weeks after last AVID follow-up visit or 1-4 months after last AVID follow-up visitOutcomesQuestionnaire response. No time point givenNotesAVID conducted in people resuscitated from ventricular fibrillation or cardioverted for ventricular tachycardia. Compared implanted cardioverter defibrillator with antiarrhythmic drugs. Primary outcome overall mortality***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearThe AVID CTC prepared the resulting 16 sets of distinct participant survey packets. These participant-specific packets were then mailed to the study co-ordinators, who distributed them to participants as instructedAdequate sequence generation?YesAuthor response \"all patients in the study were randomised. Details of the randomisation scheme are no longer extant, but given the factorial design I think it\'s safe to assume that the randomisation for each factor was by permuted blocks of size 2\"Blinding?YesParticipants were instructed to mail the completed surveys directly to the CTC in postage-paid, self-addressed return envelopes. Only their AVID study number identified participants, assuring confidentiality of their survey responsesFree of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Renfroe 2002cMethods2 x 2 x 2 x 2 factorial randomised trial (physician vs. study co-ordinator signed cover letter)DataAll surviving participants at AVID study terminationComparisons1. Cover letter signed by physician sent either by express or standard post, with or without a certificate of appreciation, 2-3 weeks after last AVID follow-up visit or 1-4 months after last AVID follow-up visit 2. Cover letter signed by study co-ordinator sent either by express or standard post, with or without a certificate of appreciation 2-3 weeks after last AVID follow-up visit or 1-4 months after last AVID follow-up visitOutcomesQuestionnaire response. No time point givenNotesAVID conducted in participants resuscitated from ventricular fibrillation or cardioverted for ventricular tachycardia. Compared implanted cardioverter defibrillator vs. antiarrhythmic drugs. Primary outcome overall mortality***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearThe AVID CTC prepared the resulting 16 sets of distinct participant survey packets. These participant-specific packets were then mailed to the study co-ordinators, who distributed them to participants as instructedAdequate sequence generation?YesAuthor response \"all patients in the study were randomised. Details of the randomisation scheme are no longer extant, but given the factorial design I think it\'s safe to assume that the randomisation for each factor was by permuted blocks of size 2\"Blinding?YesParticipants were instructed to mail the completed surveys directly to the CTC in postage-paid, self-addressed return envelopes. Only their AVID study number identified participants, assuring confidentiality of their survey responsesFree of selective outcome reporting?YesReport all outcomesOther sources of bias?UnclearInsufficient information to make a judgement on this Renfroe 2002dMethods2 x 2 x 2 x 2 factorial randomised trial (early vs. late administration of questionnaire)DataAll surviving participants at AVID study terminationComparisons1. Questionnaire sent 2-3 weeks after last AVID follow-up visit by express or standard post with cover letter signed by physician or co-ordinator with or without a certificate of appreciation 2. Questionnaire sent 1-4 months after last AVID follow-up visit, by express or standard post with cover letter signed by physician or co-ordinator with or without a certificate of appreciationOutcomesQuestionnaire response. No time point givenNotesAVID conducted in people resuscitated from ventricular fibrillation or cardioverted for ventricular tachycardia. Compared implanted cardioverter defibrillator vs. antiarrhythmic drugs. Primary outcome overall mortality***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearThe AVID CTC prepared the resulting 16 sets of distinct participant survey packets. These participant-specific packets were then mailed to the study co-ordinators, who distributed them to participants as instructedAdequate sequence generation?YesAuthor response \"all patients in the study were randomised. Details of the randomisation scheme are no longer extant, but given the factorial design I think it\'s safe to assume that the randomisation for each factor was by permuted blocks of size 2\"Blinding?YesParticipants were instructed to mail the completed surveys directly to the CTC in postage-paid, self-addressed return envelopes. Only their AVID study number identified participants, assuring confidentiality of their survey responsesFree of selective outcome reporting?YesAll defined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Severi 2011MethodsTwo 2-arm randomised trialsDataUK smokers aged ≥ 16 years participating in the Txt2stop trialComparisonsSee \'Table of characteristics\' for Severi [@b57] and Severi [@b58]OutcomesSee \'Table of characteristics\' for Severi [@b57] and Severi [@b58]NotesSee \'Table of characteristics\' for Severi [@b57] and Severi [@b58]***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear\"Concealed from the investigators\"Adequate sequence generation?Yes\"Allocated through minimisation using minim software\"Blinding?Yes\"Single blind controlled trial, with those recording and assessing outcomes blind to the intervention\"Free of selective outcome reporting?YesAll defined outcomes reported Severi 2011 1Methods2-arm randomised trialDataUK smokers aged ≥16participating in the Txt2stop trialComparisons1. Text message \"Be proud of yourself for helping medical research! Thank you for filling in the txt 2 stop questionnaire\" plus a fridge magnet: the message on the fridge magnet was placed in a sealed envelope, this said: \"medical research is important to society\" and pointed out that by taking part in TxT2stop the participants are benefiting society. Fridge magnet sent by post 16-20 weeks after randomisation. Text message sent 3 days after TxT2stop postal follow-up questionnaire 2. Text message reminding the participant the follow-up questionnaire was due 3 days after the TxT2stop questionnaire had been sent. The text message said \"Thank you for filling in the TxT2stop questionnaire\". Sent 3 days after the text to stop postal follow-up questionnaireOutcomesPrimary outcome: completed follow-up questionnaires at 30 weeks from randomisation Secondary outcome: completed follow-up questionnaires at 26 weeks from randomisationNotesTxt2stop UK-based smoking cessation trial evaluating the effectiveness of the Txt2stop mobile phone text messaging smoking cessation programme on biochemically verified continuous smoking abstinence at 6 months. Compared Txt2stop motivational messages vs. behaviour change support to text messages unrelated to quitting***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear\"Concealed from the investigators\"Adequate sequence generation?Yes\"Allocated through minimisation using minim software\"Blinding?Yes\"Single blind controlled trial, with those recording and assessing outcomes blind to the intervention\"Free of selective outcome reporting?YesAll defined outcomes reported Severi 2011 2Methods2-arm randomised trialDataUK smokers aged ≥ 16 years participating in the Txt2stop trialComparisons1. Telephone call from female principal investigator (senior clinician and researcher) to participants 6 weeks overdue returning specimen to increase participant follow-up plus standard Txt2stop follow-up procedures 2. Standard Txt2stop follow-up proceduresOutcomesCompleted cotinine sample follow-up at the end of May 2009 for Txt2stop (1 month after a telephone call)NotesTxt2stop UK-based smoking cessation trial evaluating the effectiveness of the Txt2stop mobile phone text messaging smoking cessation program on biochemically verified continuous smoking abstinence at 6 months. Compared Txt2stop motivational messages vs. behaviour change support to text messages unrelated to quitting***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear\"Concealed from the investigators\"Adequate sequence generation?Yes\"Allocated through minimisation using minim software\"Blinding?Yes\"Single blind controlled trial, with those recording and assessing outcomes blind to the intervention\"Free of selective outcome reporting?YesAll defined outcomes reported Sharp 2006aMethods2 x 2 x 2 factorial randomised trial (trial-branded pen vs. no pen: comparison 1)DataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 months\' follow-upComparisons1. TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed return envelope 2. No TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed return envelopeOutcomesResponse rates at any timeNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Sharp 2006a-hMethods2 x 2 x 2 factorial randomised trialDataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 months\' follow-upComparisons1. TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed return envelope 2. No TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed return envelope 3. TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope 4. No TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope 5. TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed return envelope 6. No TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed return envelope 7. TOMBOLA-branded pen + despatch second-class post + free post business-reply envelope 8. No TOMBOLA-branded pen + despatch second-class post + free post business-reply envelopeOutcomesResponse rates at any timeNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Sharp 2006bMethods2 x 2 x 2 factorial randomised trial (trial-branded pen vs. no pen: comparison 2)DataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 months\' follow-upComparisons1. TOMBOLA-branded pen + despatch first-class post + free post business-reply envelope 2. No TOMBOLA-branded pen + despatch first-class post + free post business-reply envelopeOutcomesResponse rates at any timeNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Sharp 2006cMethods2 x 2 x 2 factorial randomised trial (trial branded pen vs. no pen: comparison 3)DataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 months\' follow-upComparisons1. TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed return envelope 2. No TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed return envelopeOutcomesDefined outcomes reportedNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Sharp 2006dMethods2 x 2 x 2 factorial randomised trial (trial-branded pen vs. no pen: comparison 4)DataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 month follow-up.Comparisons1. TOMBOLA-branded pen + despatch second-class post + free post business-reply envelope 2. No TOMBOLA-branded pen + despatch second-class post + free post business-reply envelopeOutcomesResponse rates at any timeNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Sharp 2006eMethods2 x 2 x 2 factorial randomised trial (first vs. second-class post comparison 1)DataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 months\' follow-up.Comparisons1. TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed return envelope 2. TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed return envelopeOutcomesDefined outcomes reportedNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Sharp 2006fMethods2 x 2 x 2 factorial randomised trial (first vs. second-class post comparison 2)DataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 months\' follow-upComparisons1. No TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed return envelope 2. No TOMBOLA-branded pen + despatch second-class post + second-class stamped preaddressed return envelopeOutcomesResponse rates at any timeNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Sharp 2006gMethods2 x 2 x 2 factorial randomised trial (first vs. second-class comparison 3)DataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 months\' follow-upComparisons1. TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed return envelope 2. TOMBOLA-branded pen + despatch first-class post + free post business-reply envelopeOutcomesResponse rates at any timeNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women aged 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesDefined outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Sharp 2006hMethods2 x 2 x 2 factorial randomised trial (first vs. second-class comparison 4)DataWomen due to receive a TOMBOLA psychosocial questionnaire during June-August 2003 for 12, 18, 24, 30, 34, 36 month follow-up.Comparisons1. No TOMBOLA-branded pen + despatch first-class post + second-class stamped preaddressed return envelope 2. No TOMBOLA-branded pen + despatch first-class post + free post business-reply envelopeOutcomesResponse rates at any timeNotesTOMBOLA compared 2 management policies (colposcopy vs. 6-monthly smears) in women 20-59 years with low-grade abnormal cervical smear. Primary outcome: cumulative incidence of cervical intraepithelial neoplasia grade ≥ 2***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?Unclear2 authors did randomisationAdequate sequence generation?Unclear\"Computer randomised\"Blinding?UnclearOutcome not influenced by lack of blindingFree of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement on this Subar 2001Methods2-arm randomised trialDataParticipants aged 55-74 years from 3 centres participating in PLCO trial (control arm)Comparisons1. Diet history questionnaire DHQ (36-page food frequency questionnaire) plus 1-page questionnaire on time taken to complete questionnaire 2. PLCO food frequency questionnaire (16-page food frequency questionnaire) plus 1-page questionnaire on time taken to complete questionnaireOutcomesResponse rate. No time point givenNotesPLCO trial compared digital rectal examination, transvaginal ultrasound and chest x-ray at baseline and at 5 years vs. usual follow-up. PSA and cancer antigen CA125 at baseline, and annually for 5 years. Primary outcome: mortality from PLCO cancers***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?NoAuthor response \"none known\"Adequate sequence generation?UnclearAuthor response \"at each centre half were randomised to received\". Authors contacted \"we would have likely used some computer generated randomisation scheme\"Blinding?UnclearAuthor response \"the respondents were not blinded. Not known if personnel were \'blinded\'\"Free of selective outcome reporting?YesExpected outcome reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Sutherland 1996Methods2-arm randomised trialData226 women taking part in the feasibility study for the Canadian diet and breast cancer prevention feasibility trialComparisons1. Total design method for postal follow-up: white envelope with hospital logo and commemorative stamp; headed notepaper; reply self addressed stamped envelope enclosing contents, hand signature on letters. Postcard sent after 7 days, reminders sent twice 2. Customary method for postal follow-up: brown envelope with return address stamped on, computer-printed labels, no signature on letter, reply self addressed stamped envelope folded and inserted behind forms, no reminderOutcomesTime to return of questionnaire at 70 daysNotesCanadian diet and breast cancer prevention feasibility trial compared teaching women aged over 30 years of age with at least 50% of breast volume occupied by radiological changes of dysplasia how to reduce dietary fat to a level of 15% of calories vs. no teaching. Primary outcome recruitment and retention***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?UnclearNot clearAdequate sequence generation?YesAuthor response \"computer generated random numbers\"Blinding?UnclearAuthor response \"personel knew the allocation a subject had received but their only contact with subjects was the follow-up phone call in some allocated to the \"customary\" method\"Free of selective outcome reporting?YesExpected outcome reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Svoboda 2001Methods2-arm randomised trialDataAdults ≥ 16 years with head injury in the CRASH trial (Czech)Comparisons1. 1-page, 7-question functional dependence questionnaire sent with a covering letter and a stamped return envelope. Reminders sent after 4 and 8 weeks 2. 3-page, 16-question functional dependence questionnaire sent with a covering letter and a stamped return envelope. Reminders sent after 4 and 8 weeksOutcomesNumber of questionnaires returned within 3 monthsNotesNumbers randomised and responded provided by authors. Primary outcome for the CRASH trial death from any cause within 2 weeks of injury and death or disability at 6 months***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"central computer\"Adequate sequence generation?YesAuthor response \"random allocation central computer\"Blinding?UnclearAuthor response \"the questionnaires were packaged and sent to patients by personnel who were independent of the study\"Free of selective outcome reporting?YesExpected outcome reportedOther sources of bias?UnclearInsufficient information to make a judgement about this Tai 1997Methods2-arm randomised trialDataAll host study participants lost to follow-up in the evaluation of general practice computer templates trialComparisons1. Recorded delivery reminder letter with QoL questionnaire included, sent once 2. Telephone calls repeated up to 3 times at 10-12 a.m. or 2-5.30 p.m. Message left on answering machine after third callOutcomesNumber of questionnaires returned. No time point givenNotesEvaluation of general practice computer templates cluster randomised trial compared computerised templates for asthma and diabetes management in general practice. Primary outcome frequency of use of computer templates assessed by examining computerised records of those who responded to QoL questionnaires***Risk of bias*ItemAuthors\' judgementDescription**Allocation concealment?YesAuthor response \"computer generated by statistician independent to trial manager\"Adequate sequence generation?UnclearAuthor response \"computer generated by statistician\"Blinding?UnclearStudy personnel were not blind to the intervention the participants receivedFree of selective outcome reporting?YesExpected outcomes reportedOther sources of bias?UnclearInsufficient information to make a judgement about this[^6]

Characteristics of excluded studies *\[ordered by study ID\]*
-------------------------------------------------------------

StudyReason for exclusionArnevik 2009This retention trial was not embedded in a randomised trialAtherton 2010Comparison of Internet vs. postal questionnaires not randomisedBarry 1996Retention trial compared distribution of scores for subjects completing different questionnaire versions. Author confirmed retention/questionnaire return was not an outcome measureBednarek 2008Retention trial outcome is continuation of treatmentCox 2003Retention trial outcome treatment complianceDay 1998Retention trial measured adherence to treatment. Authors do not have retention dataEaker 2004Retention trial embedded in a cohortEdelstein 2005Retention study is not a randomised trial. Incentives not randomised. Author confirmed these were not instituted to help with retention but with adherence to pill taking and life style modification requirementsGrabowski 1995Substudy aim is retention in treatment comparing different follow-up schedules for addiction treatment trialHall 1975Not a randomised/quasi-randomised retention trialHall 1978Not a randomised/quasi-randomised retention trialHoffman 1998Retention trial embedded in a blood bank cohortHopkins 1983Retention trial embedded in a surveyIglesias 2000Retention trial embedded in a cohort of general practitioner practice participantsIglesias 2001Retention trial embedded in the recruitment phase of the host trialJohnson 2004Retention study not embedded in a randomised trialKatz 2001Retention study is not a randomised trial. Authors confirmed the effectiveness of gift incentives was not evaluated in a substudy for the Pride in Parenting trialLeidy 2000Retention study appears to be a randomised trial but no response from authors to establish if retention was an outcome. For the substudy, trial sites randomised to 1 of 2 orders of administration of quality of life questionnaires. Response rates not reported. Missing data, internal consistency reliability, mean score values, relationship between the 2 measures evaluatedMarsh 1999Host study was not a randomised trial. \"Practices were randomly allocated to the intervention group using random number tables. Each intervention practice matched with one control practice\"McAuley 1994Retention study is not a randomised trial. There is a single randomisation stratified by classes in the morning and early evening. No response from authors regarding randomisation to class timesMcBee 2009Retention study not a randomised trial. Authors confirm strategies to improve retention were not evaluated in an Age-Related Eye Disease Study 2 (AREDS2) substudyPoling 2006Substudy aim is about diagnostic compliance. 4-arm trial comparing contingency management with or without active bupropion and voucher control with or without active bupropion. Here contingency management and voucher control are aimed at getting information on the disease condition/response to treatment for the primary outcome of the host trial i.e. negative urine sample for cocaine and opioids. Contingency management and voucher control are not related to retention in the host trial but related to diagnostic compliancePuffer 2004Retention RCT was embedded in a survey. Authors confirmed that the 2 x 2 factorial study testing four different questionnaire designs was embedded in a survey.Rhoades 1998Substudy retention in treatment. 2 x 2 trial of dose and visit frequency of attending a clinic either 2 or 5 days per week. Primary outcome was retention in treatment for all randomizations. Similar to Grabowski [@b80] trialRoberts 2000Retention trial embedded in a survey about menopause servicesSchmitz 2005Substudy about compliance to treatment and pill taking behaviour rather than trial retentionSmeeth 2001abSubstudy about response to baseline assessmentStoner 1998Retention study was not a randomised trial. Host study was a cluster randomised trial. Effectiveness of vouchers not evaluated in a substudyTassopoulos 2007Not a retention randomised trialWu 1997Substudy designed to evaluate whether scores are different using 3 modes of questionnaire administration, rather than retention

Characteristics of ongoing studies *\[ordered by study ID\]*
------------------------------------------------------------

Land 2007 2Trial name or titleRandomised Evaluation of NSABP BAHO Compliance InitiativesMethodsRandomised trial embedded in Protocol B36DataParticipants or trial sites/institutions participating in the B36 trial. Pre- and postmenopausal women aged = 18 years, with histologically confirmed invasive breast adenocarcinomaComparisonsMenstrual history calendar Usual proceduresOutcomesTo improve form submission compliance in Behavioural and Health Outcomes (BAHO) protocolsStarting dateUnclearContact information<land@nsabp.pitt.edu>NotesStudy identified through personal correspondence with author B36: US-based comparison of 2 combination chemotherapy regimens to treat women with breast cancer MitchellTrial name or titleA Randomised Controlled Trial of Combined Pre-Contact and Participant Update for Increasing Questionnaire Response Rates in Older WomenMethodsRandomised trial embedded in the SCOOP screening trialDataWomen aged 70-85 years not receiving treatment for osteoporosisComparisons1. Prenotification to complete the 2-year follow-up questionnaire plus a study update 2. No study updateOutcomesResponse to postal questionnaires at 2-year follow-upStarting date2010Contact information<natasha.mitchell@york.ac.uk>NotesStudy identified through mail out to UK clinical trials units SCOOP: UK-based pragmatic randomised controlled trial of the effectiveness of screening for osteoporosis in older women for the prevention of fractures. 10-year absolute risk of fracture calculated from a World Health Organization algorithm based on screening questionnaire data, x-ray and dual-energy x-ray absorptiometry scan results compared with usual care

DATA AND ANALYSES
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Comparison 1.Addition of incentive vs none: main analysisOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention14Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Addition of monetary incentive33166Risk Ratio (M-H, Fixed, 95% CI)1.18 \[1.09, 1.28\] 1.2 Addition of offer of monetary incentive/prize draw23613Risk Ratio (M-H, Fixed, 95% CI)1.25 \[1.14, 1.38\] 1.3 Addition of non-monetary incentive66322Risk Ratio (M-H, Fixed, 95% CI)1.00 \[0.98, 1.02\] 1.4 Addition of offer of non-monetary incentive21138Risk Ratio (M-H, Fixed, 95% CI)0.99 \[0.95, 1.03\] 1.5 Addition of offer of monetary donation to charity1815Risk Ratio (M-H, Fixed, 95% CI)1.02 \[0.78, 1.32\] Comparison 2.Addition of incentive: sensitivity analysis: quasi-randomised trials removedOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention7Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Addition of monetary incentive21022Risk Ratio (M-H, Fixed, 95% CI)1.31 \[1.11, 1.55\] 1.2 Addition of non-monetary incentive51594Risk Ratio (M-H, Fixed, 95% CI)1.00 \[0.93, 1.08\] Comparison 3.Addition of incentive: separating research arms of non-factorial trials (three-/four-arm trials)Outcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention14Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Addition of monetary incentive33066Risk Ratio (M-H, Fixed, 95% CI)1.17 \[1.09, 1.27\] 1.2 Offer of monetary incentive34224Risk Ratio (M-H, Fixed, 95% CI)1.24 \[1.13, 1.37\] 1.3 Addition of non-monetary incentive810793Risk Ratio (M-H, Fixed, 95% CI)1.00 \[0.98, 1.01\] Comparison 4.Addition of telephone follow-up vs incentiveOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention1Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Telephone survey vs. monetary incentive and questionnaire1700Risk Ratio (M-H, Fixed, 95% CI)1.08 \[0.94, 1.24\] Comparison 5.Addition of monetary incentive to both study armsOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention2902Risk Ratio (M-H, Fixed, 95% CI)1.12 \[1.04, 1.22\] 1.1 Addition of GBP10 plus offer of GBP10 vs. addition of GBP5 plus offer of GBP51485Risk Ratio (M-H, Fixed, 95% CI)1.16 \[1.04, 1.30\] 1.2 Addition of GBP20 voucher offer vs. addition of GBP10 voucher offer1417Risk Ratio (M-H, Fixed, 95% CI)1.08 \[0.97, 1.21\] Comparison 6.Addition of monetary incentive vs offer of incentiveOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention2297Risk Ratio (M-H, Fixed, 95% CI)1.04 \[0.91, 1.19\] 1.1 Addition of monetary incentive vs. offer of entry into prize draw2297Risk Ratio (M-H, Fixed, 95% CI)1.04 \[0.91, 1.19\] Comparison 7.Enhanced letter versus standard letter: main analysisOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention2Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Enhanced letter vs. standard letter22479Risk Ratio (M-H, Fixed, 95% CI)1.01 \[0.97, 1.05\] Comparison 8.Communication strategies letter: total design methodOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention1Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Total design method for postal questionnaires vs. customary method1226Risk Ratio (M-H, Fixed, 95% CI)1.43 \[1.22, 1.67\] Comparison 9.Communication strategies post: main analysisOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention7Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Priority vs. regular post71888Risk Ratio (M-H, Fixed, 95% CI)1.02 \[0.95, 1.09\] Comparison 10.Communication strategies: additional reminder vs usual follow-up: main analysisOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention6Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Additional reminder vs. usual follow-up procedures63401Risk Ratio (M-H, Fixed, 95% CI)1.03 \[0.99, 1.06\] Comparison 11.Communication strategies additional reminder to trial site vs usual reminder (ICC 0.054)Outcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention1Risk Ratio (Fixed, 95% CI)Subtotals only 1.1 Monthly reminder of upcoming assessments to trial site vs. usual reminders1272Risk Ratio (Fixed, 95% CI)0.96 \[0.83, 1.11\] Comparison 12.Communication strategies: questionnaire administered early vs lateOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention1Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Early vs. late administration1664Risk Ratio (M-H, Fixed, 95% CI)1.10 \[0.96, 1.26\] Comparison 13.Communication strategies: type of reminder: main analysisOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention1Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Recorded delivery vs. telephone reminder1192Risk Ratio (M-H, Fixed, 95% CI)2.08 \[1.11, 3.87\] Comparison 14.Questionnaire strategies: new vs standard questionnaire: main analysisOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention10Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Short vs. long questionnaire57277Risk Ratio (M-H, Fixed, 95% CI)1.04 \[1.00, 1.08\] 1.2 Long and clear vs. short and condensed questionnaires1900Risk Ratio (M-H, Fixed, 95% CI)1.01 \[0.95, 1.07\] 1.3 Question order: condition first vs. generic first questions29435Risk Ratio (M-H, Fixed, 95% CI)1.00 \[0.97, 1.02\] 1.4 Questionnaire: relevant vs. less relevant to condition23893Risk Ratio (M-H, Fixed, 95% CI)1.07 \[1.01, 1.14\] Comparison 15.Questionnaire strategies: new vs standard questionnaire: sensitivity analysis quasi-randomised trial McCollOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention8Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Short vs. long questionnaire57277Risk Ratio (M-H, Fixed, 95% CI)1.04 \[1.00, 1.08\] 1.2 Long and clear vs. short and condensed questionnaires1900Risk Ratio (M-H, Fixed, 95% CI)1.01 \[0.95, 1.07\] 1.3 Questionnaire: relevant vs. less relevant to condition23893Risk Ratio (M-H, Fixed, 95% CI)1.07 \[1.01, 1.14\] Comparison 16.Behavioural strategies: main analysisOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention2Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Motivation vs. information2273Risk Ratio (M-H, Fixed, 95% CI)1.08 \[0.93, 1.24\] Comparison 17.Case managementOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention1Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Case management vs. usual follow-up1703Risk Ratio (M-H, Fixed, 95% CI)1.00 \[0.97, 1.04\] Comparison 18.Methodology strategiesOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size1 Retention1Risk Ratio (M-H, Fixed, 95% CI)Subtotals only 1.1 Open vs. blind trial design1538Risk Ratio (M-H, Fixed, 95% CI)1.37 \[1.16, 1.63\]
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Differences between protocol and review
=======================================

We grouped trials according to: the type of strategy used, whether the strategy was compared with usual follow-up or other strategies. The diversity of trials and interventions identified in the review were not anticipated. Therefore, the prespecified analyses were not appropriate. Instead, new subgroups were defined prior to analyses. We had planned to include trials that were targeted at treatment or follow-up compliance. We have only included trials that targeted follow-up compliance as the strategies used are transferable to other trials. We had planned to assess whether retention was immediate or longer term (e.g. if a response to a questionnaire was expected immediately or at time points in the future). Time points were poorly reported, where these were reported we used data for this analysis for the primary outcome time point, there was insufficient reporting of this variable to group other time points for further analysis. We had also planned to group participant or management-focused strategies. Only one unpublished trial (Land) evaluated a management-focused strategy to reduce attrition. As treatment compliance was not a focus of this review, search strategies with the terms \'compliance\' were removed for the 2009 to 2012 updates. Most untruncated \'response\' search terms were removed because hits relating to \'response\' were captured by the search term \'response\*\'. To avoid references to treatment response, the search term \'*questionnaire\'* was added to \'response\' in all remaining search terms with \'response\' or \'response\*\' to make the search specific to questionnaire response. Search updates (2009 to 2012) for EMBASE, MEDLINE and PsycINFO were de duplicated in Ovid. MEDLINE and EMBASE records were excluded for search updates in CENTRAL. C2 Spectre and ERIC searches were not updated from 1 May 2009, as C2-SPECTR geb9101.gse.upenn.edu/: was not accessible and the search platform for ERIC changed from Datastarweb to Proquest in December 2011. The latter limits searches to 10 lines of text.
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